Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3035400	s-afmaksa	u/l (u/l)	2148	2642	0.00%
3035400	s-afmaksa	— (—)	346	370	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dialysis, with operation codes

259

203

13.39

270.42

1.5

1.2

114.94

86.44

u/l

1.94

240

169

Diseases of liver

446

711

6.43

266.43

1.3

1.2

121.01

83.45

u/l

6.05

406

607

ILD medications: immunosuppressive drugs

593

1163

4.96

266.12

1.3

1.2

92.98

88.29

u/l

0.23

528

1016

Chronic kidney disease

357

484

7.52

246.53

1.4

1.2

117.69

91.33

u/l

1.21

325

403

Nephropathy related operations

244

210

12.18

240.33

1.5

1.2

130.16

94.48

u/l

1.11

225

180

Renal failure

463

756

5.70

237.69

1.3

120.12

91.05

u/l

2.00

420

637

Care involving dialysis

182

112

17.21

217.56

1.5

1.1

102.60

103.04

u/l

0.01

169

Autoimmune diseases excluding thyroid diseases

797

1196

3.73

206.48

1.3

1.2

101.85

87.57

u/l

2.04

707

1040

Autoimmune diseases excluding thyroid diseases, strict definition

773

1144

3.80

205.37

1.3

1.2

102.07

87.41

u/l

2.07

688

992

Anaemias

241

122

13.34

198.37

1.3

1.2

121.22

74.04

u/l

1.92

220

103

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

751

1560

3.48

193.58

1.3

1.2

112.71

84.48

u/l

3.62

676

1355

Renal tubulo-interstitial diseases

672

1477

3.52

179.98

1.3

1.2

113.27

83.42

u/l

3.57

607

1275

ILD medications

798

1324

3.33

176.02

1.3

1.2

97.01

90.11

u/l

0.47

701

1165

Transplanted organ and tissue status

174

148

12.26

172.54

1.4

1.1

134.41

84.64

u/l

1.13

162

128

First line medication for Crohn's disease

765

1254

3.35

169.80

1.3

1.2

97.85

90.58

u/l

0.49

674

1100

ILD medications: prednisolone, methylprednisolone, prednisone

752

1310

3.27

162.81

1.4

1.2

97.65

90.63

u/l

0.47

662

1151

Other bacterial diseases

697

1491

3.26

160.85

1.4

1.2

119.21

81.02

u/l

5.49

634

1283

Preparatory care for dialysis

119

21.11

155.49

1.4

1.2

86.39

96.76

u/l

0.30

110

Other diseases of liver

238

348

7.03

154.78

1.3

1.2

119.99

81.70

u/l

3.10

218

305

Bacterial infection, other or unspecified

442

985

4.10

153.79

1.3

1.2

118.12

80.48

u/l

7.13

415

839

Autoimmune diseases related-to ILD

629

1729

3.23

153.24

1.3

1.2

92.12

90.28

u/l

0.14

556

1514

L04AD Calcineurin inhibitors

176

185

9.88

150.82

1.4

1.1

124.91

83.07

u/l

0.97

161

160

Inflammatory bowel disease treatment related agents

779

1472

3.03

149.90

1.3

1.2

89.03

91.98

u/l

0.28

683

1298

IBD patients in KELA-register

250

428

5.95

139.02

1.4

1.2

77.08

84.37

u/l

0.54

208

372

ILD medications: azathioprine

180

217

8.49

138.32

1.3

1.1

85.09

86.75

u/l

0.06

159

186

Fibrosis and cirrhosis of liver

143

129

11.64

136.70

1.4

1.1

142.29

73.82

u/l

5.12

131

112

Second line medication for Crohn's disease

451

1280

3.56

132.55

1.3

1.2

77.64

91.59

u/l

2.38

400

1110

Inflammatory bowel disease, strict (require KELA)

250

448

5.68

132.52

1.4

1.2

77.08

86.86

u/l

0.78

208

394

Heart failure, not strict

560

1196

3.26

129.11

1.3

1.2

107.49

83.43

u/l

4.26

507

1029

Azathioprine

180

237

7.77

128.49

1.3

1.1

85.09

84.51

u/l

0.02

159

205

Glomerular disorders in diseases classified elsewhere

164

196

8.64

127.19

1.5

1.1

105.58

99.62

u/l

0.22

158

164

Extracorporeal dialysis

118

13.50

123.71

1.6

1.2

112.00

94.06

u/l

0.46

109

Examination and observation for other reasons

462

763

3.71

123.60

1.2

93.16

86.34

u/l

0.63

425

659

L04AX Other immunosuppressants

432

1256

3.48

122.39

1.2

77.40

91.53

u/l

2.38

384

1089

L04AA Selective immunosuppressants

243

460

5.39

121.48

1.3

1.2

109.58

86.94

u/l

0.68

224

401

Inflammatory bowel disease

295

660

4.54

120.79

1.4

1.2

78.17

86.43

u/l

0.75

250

578

5-aminosalicylic acid

214

362

6.01

120.49

1.4

1.2

81.43

81.81

u/l

0.02

178

314

Kidney transplant status

110

14.34

119.31

1.5

1.2

127.27

90.71

u/l

0.44

102

Dental caries

243

461

5.30

119.27

1.3

1.2

119.77

83.92

u/l

2.62

219

397

Mucosal proctocolitis

160

202

8.12

118.45

1.4

1.1

84.86

87.05

u/l

0.08

133

170

Noninfective enteritis and colitis

373

1008

3.74

117.83

1.4

1.2

86.93

87.82

u/l

0.05

322

870

Autoimmune diseases

678

1207

2.89

116.33

1.3

1.2

94.52

87.50

u/l

0.70

596

1050

Glomerular diseases

202

336

6.15

115.90

1.4

1.2

100.28

92.73

u/l

0.40

192

282

Septicaemia

315

737

4.16

114.22

1.3

1.2

135.19

83.34

u/l

2.87

284

614

Bacterial Sepsis

348

802

3.91

113.21

1.4

1.2

123.99

86.02

u/l

4.23

314

679

Tramadol

543

1136

3.10

113.13

1.3

1.2

96.47

87.45

u/l

0.99

471

988

Budesonide

163

225

7.42

111.71

1.5

1.1

88.12

79.09

u/l

0.42

141

195

Polyarthropathies

493

1047

3.16

107.58

1.2

1.3

91.88

97.40

u/l

0.50

434

920

Dentinal caries

216

415

5.26

105.32

1.3

1.2

109.43

82.53

u/l

1.94

195

354

Implicit bacterial Sepsis

307

712

4.00

104.22

1.4

1.2

126.25

84.79

u/l

4.19

276

604

Explicit Sepsis

319

807

3.83

103.38

1.3

1.2

134.90

83.34

u/l

2.93

288

687

Used for control exclusion in common control thyroid runs

611

1094

2.85

102.32

1.3

1.2

94.62

92.18

u/l

0.14

541

950

Persons encountering health services for specific procedures and health care

667

1590

2.61

101.88

1.3

1.2

96.40

90.16

u/l

0.51

603

1379

Other septicaemia

278

665

4.15

101.25

1.3

1.2

136.20

84.51

u/l

2.42

251

554

Ulcer of lower limb, not elsewhere classified

161

248

6.66

99.77

1.3

1.2

124.61

85.42

u/l

3.52

149

207

GASTRO-related operations

456

686

3.35

98.61

1.2

1.1

93.18

69.77

u/l

4.03

411

565

Any gastric operation

456

686

3.35

98.61

1.2

1.1

93.18

69.77

u/l

4.03

411

565

Ulcerative colitis

226

482

4.76

98.30

1.4

1.2

80.89

84.96

u/l

0.25

188

416

Abnormal findings on examination of blood, without diagnosis

338

905

3.53

96.63

1.3

1.2

112.60

96.13

u/l

1.48

301

782

Fever of other and unknown origin

363

1022

3.32

94.23

1.3

1.2

107.90

83.46

u/l

3.50

334

885

Oral corticosteroids

619

1447

2.60

93.24

1.3

1.2

94.47

91.65

u/l

0.23

547

1275

Crohn disease

143

214

6.83

91.03

1.4

1.1

75.54

79.92

u/l

0.21

123

182

Unspecified kidney failure

119

145

8.43

90.84

1.2

133.46

95.31

u/l

0.51

103

123

Acute renal failure

178

331

5.47

90.78

1.3

129.68

86.13

u/l

2.76

168

273

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

181

343

5.37

90.42

1.4

1.2

78.77

90.18

u/l

0.80

149

297

Reimbursement for rheumatic diseases

415

1419

2.94

89.40

1.3

1.2

98.95

86.04

u/l

1.19

374

1226

Ulcerative colitis (strict definition, require KELA)

172

316

5.54

88.93

1.4

1.2

78.83

90.08

u/l

0.73

141

273

Cholangitis (primary sclerosing, PSC)

11.08

88.38

1.3

1.1

155.11

81.00

u/l

2.68

Any reimbursement code in KELA

290

334

4.37

88.11

1.2

1.1

89.70

81.29

u/l

0.55

255

292

Aplastic and other anaemias

328

930

3.38

87.95

1.3

1.2

124.89

88.01

u/l

2.06

296

794

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

167

305

5.58

86.92

1.4

1.2

79.39

89.68

u/l

0.62

137

262

Disorders resulting from impaired renal tubular function

15.06

86.75

1.4

1.2

123.37

84.64

u/l

0.33

Dialysis

14.71

84.88

1.5

1.2

91.58

92.78

u/l

0.02

Other anaemias

305

864

3.44

84.59

1.3

1.2

124.55

89.00

u/l

1.76

275

739

Implicit Sepsis

466

1319

2.77

84.48

1.3

1.2

115.00

83.30

u/l

4.44

418

1137

Influenza and pneumonia

622

1692

2.43

83.50

1.3

1.2

110.10

82.43

u/l

5.51

565

1470

Other and unspecified anaemias

300

852

3.44

83.29

1.3

1.2

125.03

89.44

u/l

1.71

270

729

Pneumonias (Asthma/COPD co-morbidities)

593

1688

2.45

81.93

1.3

1.2

111.97

82.86

u/l

5.66

537

1465

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

556

1371

2.56

81.74

1.3

1.2

109.83

81.63

u/l

5.73

503

1188

556

1371

2.56

81.74

1.3

1.2

109.83

81.63

u/l

5.73

503

1188

All pneumoniae

596

1697

2.44

81.55

1.3

1.2

111.97

83.01

u/l

5.66

540

1474

Insulin, intermediate and long-acting

361

1180

3.03

81.45

1.3

1.2

117.11

89.91

u/l

3.48

326

1019

Other Crohn's disease

9.88

81.00

1.4

1.1

74.81

72.11

u/l

0.10

Heart failure,strict

340

754

3.28

80.79

1.2

118.85

81.38

u/l

6.57

302

641

Insulin, fast-acting

264

733

3.64

80.43

1.3

1.2

121.59

86.71

u/l

3.79

239

629

Diabetic nephropathy, excluding more controls

157

229

5.85

80.05

1.4

1.2

113.18

103.17

u/l

0.38

148

191

Disorders of parathyroid gland

200

454

4.43

79.09

1.3

1.2

70.08

86.14

u/l

1.86

175

387

Insulin, combination of fast acting with intermediate-acting or long-acting

392

1283

2.84

77.77

1.3

1.2

117.85

89.35

u/l

4.10

354

1109

Heart failure and antihypertensive medication

210

301

4.67

77.10

1.2

120.63

93.87

u/l

1.63

190

252

Insulin, fast-acting or short human

266

768

3.50

76.39

1.3

1.2

121.40

87.53

u/l

3.67

241

656

Secondary hypertension

107

9.01

76.24

1.4

1.1

85.61

83.34

u/l

0.06

Metabolic disorders

573

1470

2.44

76.14

1.3

1.2

94.13

88.52

u/l

0.55

510

1282

Osteopathies and chondropathies

377

1265

2.85

75.85

1.3

1.2

94.71

86.81

u/l

0.63

336

1093

Diabetic nephropathy

160

317

5.09

74.76

1.4

1.2

114.44

107.19

u/l

0.28

151

271

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

571

1697

2.38

74.44

1.3

1.2

112.30

83.46

u/l

5.30

518

1472

Nonalcoholic fatty liver disease

118

179

6.78

74.36

1.2

1.1

102.28

81.18

u/l

0.69

105

154

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

142

261

5.55

73.52

1.3

1.2

147.57

89.87

u/l

3.24

132

219

Malaise and fatigue

320

860

3.13

73.39

1.2

99.39

82.05

u/l

2.29

280

746

Nutritional anaemias

333

1095

2.99

73.25

1.3

1.2

118.05

86.62

u/l

1.63

301

946

Type 1 diabetes

198

482

4.15

72.66

1.3

1.2

122.87

82.98

u/l

3.63

182

413

Insulin medication

392

1223

2.76

72.63

1.3

1.2

117.85

88.55

u/l

4.26

354

1064

Ulcerative colitis, NAS

135

240

5.73

72.38

1.2

1.1

77.66

82.36

u/l

0.24

111

201

Hyperparathyroidism

177

392

4.54

72.38

1.3

1.2

66.79

86.30

u/l

2.60

155

337

Pneumonia, organism unspecified

524

1577

2.42

71.35

1.3

1.2

115.23

83.61

u/l

5.55

476

1363

Certain infectious and parasitic diseases

550

1125

2.46

70.08

1.3

1.2

94.37

79.70

u/l

2.32

482

970

Abnormal serum enzyme levels

207

535

3.86

68.64

1.3

117.64

98.33

u/l

1.33

182

450

General symptoms and signs

600

1300

2.32

67.80

1.3

1.2

99.90

82.11

u/l

2.95

525

1139

Other disorders of kidney and ureter

128

231

5.66

67.64

1.3

1.1

104.94

91.08

u/l

0.17

116

195

Iron deficiency anaemia

282

913

3.09

66.12

1.3

1.2

125.48

86.04

u/l

1.83

256

783

Disorders of gallbladder, biliary tract and pancreas

569

1629

2.26

65.03

1.3

1.2

110.61

86.16

u/l

4.12

505

1420

Type 1 diabetes, wide definition, subgroup 1

161

365

4.46

64.94

1.3

1.2

123.69

77.21

u/l

4.11

152

314

Heart failure, strict

358

931

2.79

64.73

1.2

117.00

87.24

u/l

4.66

317

803

Diseases of oesophagus, stomach and duodenum

594

1629

2.23

64.37

1.3

1.2

93.21

90.51

u/l

0.23

520

1435

Disorders of other endocrine glands

297

1002

2.94

63.93

1.3

1.2

91.46

87.79

u/l

0.09

262

870

Crohn's disease NAS

8.76

63.81

1.4

1.1

75.97

70.01

u/l

0.23

Condition for Implicit Sepsis (Organ dysfunction codes)

481

1483

2.37

62.89

1.3

1.2

114.96

82.88

u/l

4.67

435

1278

Chronic periodontitis

137

284

4.91

61.91

1.5

1.2

92.24

88.00

u/l

0.19

125

241

Other and unspecified iron deficiency

226

676

3.38

61.58

1.3

1.2

125.12

85.19

u/l

1.41

205

574

Ulcerative colitis (strict definition, all Crohn cases excluded)

127

250

5.16

60.91

1.3

1.1

77.14

88.77

u/l

0.62

104

215

Other heart diseases

290

626

3.08

60.88

1.3

1.2

106.45

87.32

u/l

1.12

265

543

All-cause Heart Failure

346

917

2.74

60.58

1.2

115.42

87.83

u/l

4.04

306

791

Acute tubulo-interstitial nephritis

353

1209

2.61

59.15

1.3

1.2

118.44

81.02

u/l

2.23

313

1038

Erysipelas

315

1054

2.75

58.82

1.3

1.2

112.14

83.22

u/l

3.47

278

896

Type 1 diabetes, wide definition

163

403

4.08

58.70

1.3

1.2

123.19

81.03

u/l

3.49

154

349

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

529

1632

2.21

58.29

1.3

1.2

110.99

85.21

u/l

2.04

472

1421

Hypertensive diseases (excluding secondary)

311

618

2.94

58.11

1.3

1.2

94.56

83.07

u/l

0.81

279

538

Diseases of arteries, arterioles and capillaries (FINNGEN)

177

305

4.10

57.06

1.3

1.2

94.59

80.77

u/l

0.94

159

260

Other diseases of intestines

560

1506

2.17

56.62

1.3

1.2

97.06

88.20

u/l

0.84

490

1327

Implicit viral Sepsis

138

314

4.45

55.59

1.3

1.2

107.30

79.25

u/l

2.29

128

266

Insulin, fast-acting (human)

117

233

5.09

55.38

1.4

1.1

127.30

87.24

u/l

2.17

108

195

Sub-endpoint used in defining T1D endpoints

199

577

3.42

55.30

1.3

1.2

120.10

93.28

u/l

1.87

184

491

Hypertension, essential

430

1020

2.42

55.20

1.3

1.2

91.49

88.39

u/l

0.22

386

886

Viral Sepsis

138

316

4.42

55.15

1.3

1.2

107.30

79.08

u/l

2.32

128

268

Gastrointestinal diseases

296

492

3.03

55.14

1.2

94.13

71.11

u/l

2.92

262

420

Opioids

517

1215

2.24

54.96

1.3

1.2

92.05

86.14

u/l

0.53

450

1064

Exposure to unspecified factor

522

1907

2.13

54.21

1.2

87.55

93.87

u/l

0.65

450

1687

Intestinal infectious diseases

505

1830

2.16

53.99

1.3

1.2

99.31

88.60

u/l

1.17

451

1597

Codeine

486

1187

2.26

53.25

1.2

85.80

86.83

u/l

0.08

420

1038

Pain in limb

430

1356

2.30

52.96

1.2

90.67

94.81

u/l

0.35

372

1191

Other disorders of skin and subcutaneous tissue

400

1586

2.32

52.85

1.3

1.2

107.78

87.55

u/l

2.28

352

1383

Hypertension

432

1039

2.36

52.77

1.3

1.2

96.68

89.45

u/l

0.52

388

905

Complications of surgical and medical care, not elsewhere classified

529

1803

2.11

52.75

1.3

1.2

99.92

89.36

u/l

1.33

469

1580

Malignant neoplasm of breast, HER2-negative

341

987

2.56

52.66

1.2

67.93

86.17

u/l

3.70

311

865

Other inflammatory liver diseases

107

7.39

52.63

1.2

1.1

99.73

76.88

u/l

1.08

Persons encountering health services for other counselling and medical advice, not elsewhere classified

598

1664

2.06

52.60

1.3

1.2

97.98

87.13

u/l

1.26

539

1452

Hypertensive diseases

431

1040

2.36

52.31

1.3

1.2

96.71

89.40

u/l

0.52

387

906

Infections, IBD-co-morbidities

115

156

5.42

51.95

1.3

106.33

104.73

u/l

0.04

100

140

Diseases of arteries, arterioles and capillaries

383

1201

2.39

51.70

1.3

1.2

108.37

88.91

u/l

2.34

342

1037

Diarrhoea and gastroenteritis of presumed infectious origin

378

1463

2.36

51.68

1.3

1.2

111.28

87.41

u/l

1.19

338

1271

Malignant neoplasm of breast

346

998

2.52

51.61

1.2

68.16

86.10

u/l

3.63

316

875

Direct fill therapy

117

249

4.77

51.27

1.4

1.2

92.11

87.28

u/l

0.19

103

219

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

306

754

2.67

49.87

1.2

68.47

80.05

u/l

1.61

283

664

Gout, FINNGEN

175

510

3.47

49.82

1.3

108.05

103.94

u/l

0.17

153

434

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

306

755

2.67

49.75

1.2

68.47

80.11

u/l

1.62

283

665

Finngen Rheumatological endpoints

504

1342

2.15

49.63

1.2

86.94

94.26

u/l

0.78

445

1180

Cardiovascular diseases (excluding rheumatic etc)

327

726

2.61

49.40

1.3

1.2

96.60

86.32

u/l

0.54

297

634

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

109

7.04

49.22

1.3

1.1

63.59

80.37

u/l

0.86

Crohn disease (strict definition, require KELA, min 2 HDR)

7.42

48.82

1.3

1.1

65.21

79.43

u/l

0.64

Crohn's disease of large intestine

8.32

48.42

1.3

1.1

79.85

66.97

u/l

0.48

Gout

175

468

3.44

48.14

1.3

108.05

103.76

u/l

0.18

153

396

Crohn's disease of small intestine

106

7.04

47.94

1.5

1.1

72.75

74.40

u/l

0.05

Care involving use of rehabilitation procedures

345

1396

2.36

47.61

1.2

89.62

91.19

u/l

0.08

304

1204

Heart failure and bmi 25plus

211

460

3.19

47.55

1.2

114.91

82.09

u/l

3.62

182

398

Crohn disease (strict definition, require KELA)

102

7.13

47.10

1.3

1.2

65.21

80.73

u/l

0.72

Pain in joint

313

823

2.53

46.20

1.2

81.64

94.29

u/l

1.34

275

717

Benign neoplasm: Colon

267

768

2.68

45.87

1.2

96.57

88.20

u/l

0.57

227

662

Diseases of the digestive system

265

1021

2.61

45.74

1.3

1.2

110.03

91.18

u/l

1.83

242

874

Endocrine, nutritional and metabolic diseases

398

877

2.32

45.29

1.3

1.2

88.36

84.38

u/l

0.27

358

764

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

457

1265

2.14

45.24

1.3

1.2

97.58

89.96

u/l

0.34

414

1099

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

457

1267

2.14

45.05

1.3

1.2

97.58

89.99

u/l

0.34

414

1101

Malignant neoplasm, wide definition for exclusion

457

1268

2.14

44.97

1.3

1.2

97.58

89.93

u/l

0.34

414

1102

Other arthritis (FG)

195

648

3.03

44.77

1.2

1.3

87.25

86.04

u/l

0.06

179

551

Malignant neoplasm

465

1307

2.12

44.74

1.3

1.2

96.72

90.50

u/l

0.26

416

1134

Benign neoplasm of colon, rectum, anus and anal canal

294

832

2.54

44.58

1.2

100.35

87.14

u/l

1.06

251

719

Adjustment and management of implanted device

123

305

4.08

44.36

1.2

113.88

96.27

u/l

0.96

113

257

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

231

671

2.82

44.16

1.2

70.38

79.84

u/l

0.94

212

588

Other and unspecified polyneuropathies, also in other diseases

135

360

3.80

44.01

1.3

1.2

106.34

87.99

u/l

1.07

119

304

Codeine or tramadol medication

582

1666

1.94

43.55

1.2

84.10

94.28

u/l

1.58

508

1465

Other heart diseases, wide

465

1398

2.07

42.72

1.3

1.2

101.29

87.76

u/l

1.31

418

1220

Any event in cancer register

466

1336

2.08

42.63

1.3

1.2

99.64

89.72

u/l

0.47

416

1163

Polyneuropathies and other disorders of the peripheral nervous system

146

420

3.52

42.53

1.2

105.02

86.28

u/l

1.24

129

351

Bleeding

439

1542

2.08

42.31

1.3

1.2

108.54

87.93

u/l

2.80

388

1336

Complications of procedures, not elsewhere classified

421

1755

2.08

42.14

1.3

1.2

100.61

89.21

u/l

1.28

373

1537

Asthma, excluding more controls

372

868

2.29

41.98

1.3

1.2

94.90

74.03

u/l

3.23

328

749

Medical observation and evaluation for suspected diseases and conditions

352

766

2.36

41.92

1.3

1.2

92.84

86.17

u/l

0.44

310

662

Chronic periodontitis, complicated

172

5.16

41.71

1.5

1.2

102.96

91.45

u/l

0.46

149

Other disorders of fluid, electrolyte and acid-base balance

185

597

3.01

41.64

1.3

1.2

103.90

86.27

u/l

1.33

163

500

Cardiovascular diseases

280

588

2.60

41.42

1.2

96.49

87.09

u/l

0.39

252

511

Pain, not elsewhere classified

166

528

3.17

41.12

1.3

1.2

94.91

77.14

u/l

1.40

151

454

Oxycodone

203

697

2.84

41.08

1.5

1.2

113.79

87.92

u/l

1.88

190

600

Diseases of pulp and periapical tissues

202

722

2.82

40.67

1.3

1.2

91.26

85.49

u/l

0.38

185

614

Oedema, not elsewhere classified

186

632

2.95

40.66

1.3

1.2

104.09

80.67

u/l

2.10

162

544

Peripheral artery disease

246

767

2.60

40.31

1.3

115.18

92.08

u/l

2.20

226

656

Asthma, unspecified (mode), excluding more controls

260

811

2.53

40.18

1.3

1.2

89.47

73.89

u/l

1.87

227

699

Sulfasalazine

176

588

3.02

40.09

1.3

1.2

79.21

85.07

u/l

0.35

160

507

Unspecified privation

178

4.97

40.05

1.2

113.31

83.99

u/l

1.14

153

Peripheral artery operations in Hilmo

220

4.47

39.35

1.4

1.2

127.81

92.51

u/l

1.61

188

Osteoporosis

180

584

2.97

39.34

1.3

1.2

96.96

81.57

u/l

0.86

155

505

Other specified/unspecified arthritis

171

570

3.03

39.13

1.2

1.3

81.12

88.07

u/l

0.56

158

490

Gout, strict definition

114

296

3.90

38.66

1.2

1.3

108.15

97.91

u/l

0.40

101

245

Gout, idiopatic and unspecified

146

448

3.29

38.45

1.3

108.32

102.19

u/l

0.25

130

374

Other soft tissue disorders, not elsewhere classified

451

1392

2.01

38.23

1.2

87.52

95.26

u/l

0.85

395

1223

Continuous positive airway pressure

122

281

3.78

38.07

1.2

1.3

149.86

73.97

u/l

1.58

114

243

Complications of medical and surgical care

383

1775

2.06

37.89

1.3

1.2

107.78

88.25

u/l

2.57

342

1547

Infections of the skin and subcutaneous tissue

295

1300

2.27

37.78

1.3

1.2

100.59

93.09

u/l

0.47

265

1128

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

327

1505

2.18

37.71

1.3

1.2

104.87

88.72

u/l

1.73

289

1303

Diabetes, varying definitions

514

1613

1.91

37.52

1.3

1.2

105.74

84.63

u/l

3.14

457

1413

Gout, unspecified

124

349

3.59

37.40

1.3

107.92

98.20

u/l

0.41

112

287

Diseases of the skin and subcutaneous tissue

499

1283

1.96

37.30

1.3

1.2

93.95

86.62

u/l

0.61

437

1122

Disorders of lipoprotein metabolism and other lipidaemias

423

1316

2.03

37.01

1.2

90.76

89.77

u/l

0.07

374

1141

Asthma

382

966

2.13

36.35

1.3

1.2

93.55

77.91

u/l

2.08

337

835

Persons encountering health services in other circumstances, wide

587

1670

1.83

36.29

1.3

1.2

100.92

86.99

u/l

1.80

526

1458

COPD/asthma/ILD related infections

520

1373

1.90

35.88

1.3

1.2

92.36

81.82

u/l

1.56

465

1190

COPD/asthma related infections

520

1373

1.90

35.88

1.3

1.2

92.36

81.82

u/l

1.56

465

1190

Bacterial pneumoniae

219

762

2.56

35.68

1.3

1.2

127.54

86.94

u/l

1.41

202

647

Disorders of mineral metabolism

135

5.36

35.59

1.5

1.1

85.23

93.44

u/l

0.26

114

Other specific joint derangements/joint disorders

350

1105

2.13

35.43

1.2

1.3

79.48

94.11

u/l

2.18

307

976

Bacterial pneumonia, not elsewhere classified

209

714

2.61

35.33

1.3

1.2

111.34

88.02

u/l

2.27

192

603

Neoplasms

333

805

2.22

35.25

1.2

94.93

90.48

u/l

0.13

293

706

Diabetes mellitus

508

1621

1.88

35.17

1.3

1.2

105.59

84.69

u/l

3.06

452

1419

Certain disorders involving the immune mechanism

135

418

3.27

35.11

1.3

1.2

102.56

89.33

u/l

0.49

126

358

Glomerulonephritis

171

4.75

35.02

1.3

1.2

86.48

95.57

u/l

0.29

145

L02BG Aromatase inhibitors

205

800

2.59

34.91

1.2

64.11

84.56

u/l

3.98

187

698

Asthma (only as main-diagnosis), excluding more controls

322

868

2.22

34.86

1.3

1.2

93.26

74.03

u/l

2.43

290

749

Chronic periapical parodontitis

134

415

3.26

34.81

1.3

1.2

87.91

84.64

u/l

0.16

124

354

Hypothyroidism (congenital or acquired)

102

130

4.53

34.63

1.2

82.67

73.10

u/l

0.47

110

Rheumatoid arthritis

199

691

2.64

34.60

1.2

1.3

83.51

92.37

u/l

0.72

179

602

Asthma, unspecified (mode)

264

901

2.33

34.46

1.3

1.2

89.47

77.42

u/l

1.28

230

777

Other noninfective gastroenteritis and colitis

151

506

3.01

34.25

1.3

1.2

100.93

88.39

u/l

0.57

132

436

Explicit bacterial Sepsis

147

5.03

34.25

1.5

1.1

110.64

84.37

u/l

0.85

123

Medicines for HER+ breast cancer

235

961

2.40

34.03

1.2

70.62

83.61

u/l

1.56

215

838

Chronic gastritis

172

622

2.79

34.01

1.2

100.60

88.80

u/l

0.69

146

539

Atherosclerosis, excluding cerebral and coronary sclerosis

223

716

2.51

33.97

1.3

110.07

91.13

u/l

1.72

204

612

Malignant neoplasm of breast, HER-positive

228

934

2.43

33.88

1.2

69.55

83.76

u/l

1.75

209

814

Covid-19 confirmed case

161

563

2.88

33.87

1.4

1.2

112.27

85.66

u/l

2.05

150

484

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

482

1572

1.88

33.72

1.3

1.2

111.68

85.48

u/l

3.85

429

1375

Other diseases of intestine

218

4.18

33.63

1.3

1.2

113.18

86.09

u/l

0.74

184

Hypothyroidism, levothyroxine purchases

100

129

4.48

33.57

1.2

83.44

72.79

u/l

0.53

109

Hypothyroidism and >3 levothyroxin purchases

100

129

4.48

33.57

1.2

83.44

72.79

u/l

0.53

109

Deposits [accretions] on teeth

5.95

33.26

1.3

1.2

207.13

79.45

u/l

1.08

Statin medication

359

969

2.09

32.90

1.3

1.2

96.63

89.35

u/l

0.49

310

860

Atrial fibrillation and flutter

181

423

2.81

32.68

1.3

1.2

98.08

82.91

u/l

1.00

167

362

Abnormalities of breathing

424

1300

1.94

32.64

1.2

106.06

87.06

u/l

2.23

376

1135

Viral pneumonia

195

4.31

32.28

1.4

1.2

100.54

82.80

u/l

0.84

164

Acute peritonitis

104

5.79

32.12

1.4

1.2

93.30

78.93

u/l

0.51

Streptococcal septicaemia

118

5.42

32.11

1.5

1.1

118.56

81.32

u/l

1.15

Cutaneous abscess, furuncle and carbuncle

149

516

2.91

31.96

1.3

1.2

100.53

82.55

u/l

1.06

135

443

Diabetes medication

501

1677

1.82

31.84

1.3

1.2

107.20

84.71

u/l

3.76

446

1468

Low back pain

357

1377

2.00

31.72

1.3

1.2

93.84

90.89

u/l

0.21

321

1210

Other retinal disorders

323

1259

2.07

31.60

1.3

1.2

98.97

90.72

u/l

0.69

276

1106

Ascites

120

5.35

31.56

1.3

1.2

160.86

79.69

u/l

3.27

101

Diaphragmatic hernia

218

918

2.39

31.54

1.2

85.33

87.56

u/l

0.10

182

797

Non-ischemic cardiomyopathy

169

506

2.76

31.44

1.2

1.3

107.91

88.61

u/l

1.33

150

433

GI-bleeding

174

660

2.65

31.37

1.2

105.57

95.85

u/l

0.59

159

558

Spondyloarthritis

108

312

3.49

31.35

1.2

124.83

91.08

u/l

1.33

100

265

Diabetes, insulin treatment (Kela reimbursement)

499

1689

1.81

31.30

1.3

1.2

111.76

85.71

u/l

4.00

442

1475

Cardiac arrhythmias

296

906

2.17

31.22

1.3

1.2

96.44

77.43

u/l

1.86

268

795

Benign neoplasms

322

859

2.13

31.18

1.3

1.2

81.94

90.84

u/l

0.99

276

753

Asthma (mode)

361

976

2.04

31.05

1.3

1.2

93.09

78.00

u/l

1.99

319

844

Cholelithiasis, broad definition with cholecystitis

423

1541

1.89

30.87

1.2

96.67

84.72

u/l

1.45

374

1344

Haemorrhage from respiratory passages

187

684

2.55

30.70

1.2

108.51

85.69

u/l

2.02

163

586

Bacterial pneumonia (organism specified)

231

915

2.31

30.45

1.3

1.2

125.46

89.95

u/l

1.26

214

777

Crohn disease (strict definition, all UC cases excluded)

6.46

30.40

1.3

1.1

65.25

75.17

u/l

0.32

Fall on same level

539

1712

1.76

30.27

1.3

1.2

100.70

89.78

u/l

1.00

469

1517

Other diseases of the digestive system

172

662

2.62

30.14

1.2

105.70

95.27

u/l

0.65

158

559

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

296

1442

2.06

29.84

1.3

1.2

107.04

88.60

u/l

1.91

261

1249

Cholelithiasis

408

1526

1.88

29.65

1.2

96.36

84.43

u/l

1.41

358

1332

Alcoholic liver disease

154

4.61

29.63

1.2

1.1

139.35

89.35

u/l

1.85

129

Dyspnoea

430

1801

1.84

29.41

1.2

107.57

87.52

u/l

2.53

378

1574

Nausea and vomiting

149

530

2.78

29.40

1.4

1.2

124.80

80.26

u/l

1.94

135

446

Ulcerative rectosigmoiditis

124

5.07

29.38

1.5

1.1

89.35

74.13

u/l

0.63

104

Biological medication for rheuma

104

307

3.42

29.27

1.1

1.2

77.13

89.11

u/l

0.74

267

Asthma (only as main-diagnosis)

327

966

2.05

29.27

1.3

1.2

92.92

77.91

u/l

1.66

292

835

Disorders of choroid and retina

397

1541

1.88

29.14

1.3

1.2

97.00

91.69

u/l

0.45

338

1356

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

223

595

2.39

29.10

1.3

1.2

101.55

82.27

u/l

1.88

194

516

Type 2 diabetes, wide definition

403

1397

1.89

29.10

1.3

1.2

104.97

85.76

u/l

2.53

354

1215

Other ulcerative colitis

6.04

29.06

1.4

1.1

100.49

75.50

u/l

0.97

Fracture of femur

145

472

2.83

28.92

1.3

1.1

103.30

90.53

u/l

0.47

131

401

Asthma-related pneumonia or sepsis

195

812

2.41

28.86

1.3

1.2

103.38

88.46

u/l

1.17

175

690

Asthma, hospital admissions 3, pneumonia

195

812

2.41

28.86

1.3

1.2

103.38

88.46

u/l

1.17

175

690

Asthma-related pneumonia

194

811

2.40

28.47

1.3

1.2

103.59

88.49

u/l

1.18

174

689

Hernia of abdominal wall, postoperative

237

3.74

28.40

1.3

1.1

96.95

66.15

u/l

1.97

189

Systemic connective tissue disorders

204

875

2.35

28.37

1.3

1.2

87.34

85.13

u/l

0.14

181

758

Artificial opening status

6.40

28.31

1.3

1.1

162.49

89.97

u/l

1.12

Seropositive rheumatoid arthritis

155

586

2.66

28.07

1.2

80.11

85.27

u/l

0.37

142

507

Lower back pain or/and sciatica

479

1894

1.76

28.03

1.3

1.2

93.80

90.16

u/l

0.31

423

1662

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

130

4.85

27.85

1.4

1.2

125.02

81.59

u/l

1.33

111

Primary_lymphoid and hematopoietic malignant neoplasms

126

431

2.95

27.68

1.2

142.00

91.72

u/l

0.90

118

368

Other nutritional deficiencies

303

1494

1.99

27.68

1.3

1.2

82.84

87.92

u/l

0.48

267

1302

Benign neoplasm of colon, rectum, anus and anal canal

310

1422

1.98

27.38

1.2

101.22

90.60

u/l

0.84

266

1243

Hypertensive heart and/or renal disease

134

359

2.91

27.16

1.2

1.3

112.68

90.13

u/l

1.35

126

305

Excluding asthma or asthma-COPD overlap

375

977

1.93

27.11

1.2

95.05

77.57

u/l

2.60

334

846

Benign neoplasm: Colon

270

1291

2.06

27.09

1.2

98.27

90.16

u/l

0.57

230

1128

Antihypertensive medication - note that there are other indications

255

632

2.21

27.05

1.2

93.66

84.06

u/l

0.51

230

547

Viral pneumonia (unknown virus, not influenza)

5.50

26.97

1.4

1.2

110.83

86.64

u/l

0.82

Codes for special purposes

217

977

2.23

26.89

1.4

1.2

108.31

84.03

u/l

2.53

203

844

Pleural effusion

291

3.37

26.67

1.2

112.69

90.26

u/l

0.98

245

Benign neoplasm of other and ill-defined parts of digestive system

103

321

3.24

26.62

1.3

1.2

94.66

85.81

u/l

0.46

269

Asthma, hospital admission 2, infections

285

1405

2.00

26.60

1.3

1.2

100.91

92.78

u/l

0.54

257

1227

Asthma-related infections

285

1405

2.00

26.60

1.3

1.2

100.91

92.78

u/l

0.54

257

1227

Congenital malformations of the urinary system

5.53

26.52

1.4

1.2

168.60

83.87

u/l

0.52

Speech therapy

162

647

2.52

26.41

1.2

88.10

85.77

u/l

0.09

135

559

Gingivitis and periodontal diseases

419

1184

1.83

26.23

1.3

1.2

99.43

91.44

u/l

0.32

369

1025

ILD differential diagnosis

371

976

1.91

26.10

1.2

95.42

78.00

u/l

2.57

332

844

Other pulmonary diagnosis

371

977

1.91

26.03

1.3

1.2

94.56

77.57

u/l

2.45

330

846

Provisional assignment of new diseases of uncertain etiology

215

978

2.21

26.00

1.4

1.2

108.19

84.10

u/l

2.46

201

845

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

104

4.72

25.97

1.1

1.3

93.25

91.91

u/l

0.03

UC patients in KELA-register (code 208), prior to 1994

5.96

25.79

1.6

1.2

69.10

82.74

u/l

0.78

COPD differential diagnosis

370

977

1.90

25.76

1.2

95.32

78.06

u/l

2.52

331

845

245

3.55

25.62

1.3

1.1

86.62

78.61

u/l

0.34

214

Diabetic retinopathy, excluding more controls

152

312

2.77

25.59

1.4

1.2

111.13

97.94

u/l

0.63

134

269

Other bacterial intestinal infections

106

346

3.09

25.37

1.3

1.2

103.77

87.84

u/l

0.77

296

Other diseases of blood and blood-forming organs, wide

133

494

2.72

25.15

1.2

142.90

86.90

u/l

1.09

121

425

Pure hypercholesterolaemia

343

1223

1.89

25.08

1.3

1.2

94.43

90.23

u/l

0.29

303

1059

Rheumatoid arthritis, including avohilmo

214

990

2.18

24.89

1.2

84.49

86.46

u/l

0.13

192

858

Spondylopathies

385

1285

1.83

24.82

1.2

94.01

93.14

u/l

0.05

335

1126

Adalimumab

143

4.39

24.79

1.2

1.1

70.85

83.85

u/l

0.73

123

Type 2 diabetes

457

1568

1.74

24.77

1.2

102.04

85.64

u/l

2.39

404

1371

Tumor necrosis factor alpha inhibitors

271

3.35

24.63

1.1

1.2

72.32

89.67

u/l

1.35

236

Pain in throat and chest

376

1260

1.83

24.44

1.2

92.98

86.29

u/l

0.57

334

1097

Constipation

417

1710

1.75

24.29

1.3

1.2

89.25

91.92

u/l

0.21

371

1494

Diseases of peritoneum

194

3.81

24.14

1.3

1.2

94.26

83.07

u/l

0.41

166

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

156

292

2.69

24.13

1.1

94.75

70.24

u/l

1.69

136

249

Cystic kidney disease

6.58

24.01

1.3

1.1

190.18

80.87

u/l

0.50

Depression

438

1754

1.72

23.96

1.2

100.80

85.55

u/l

1.66

386

1534

Abdominal and pelvic pain

454

1316

1.74

23.84

1.2

95.75

85.62

u/l

1.10

403

1140

Other diseases of urinary system

465

1531

1.71

23.83

1.2

93.10

90.31

u/l

0.22

409

1345

Other CVD (FINNGEN)

129

4.19

23.81

1.4

1.2

76.18

88.45

u/l

0.45

109

All influenza

123

452

2.74

23.74

1.4

1.2

98.24

85.66

u/l

0.73

116

383

Other systemic involvement of connective tissue (FG)

144

572

2.52

23.43

1.2

87.26

86.38

u/l

0.04

126

491

Diseases of oral cavity, salivary glands and jaws

411

1189

1.78

23.41

1.2

96.14

91.38

u/l

0.35

361

1030

Diverticular disease of intestine

335

1204

1.85

23.18

1.2

87.29

89.12

u/l

0.11

291

1053

Arthropathies

401

1145

1.79

23.18

1.2

1.3

83.89

96.25

u/l

1.50

357

1012

Chronic pancreatitis

219

3.56

23.05

1.3

1.2

134.73

84.46

u/l

2.24

186

Cystitis

398

1386

1.76

22.87

1.2

89.43

87.48

u/l

0.14

351

1215

Bacterial intestinal infections, IBD co-morbidities

107

373

2.89

22.85

1.3

1.2

104.68

90.79

u/l

0.65

320

Dorsalgia

447

1415

1.72

22.83

1.2

90.20

90.77

u/l

0.04

392

1247

Other functional intestinal disorders

211

955

2.11

22.71

1.3

1.2

104.19

86.10

u/l

1.53

193

833

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

304

1520

1.86

22.64

1.2

106.31

89.35

u/l

1.83

267

1315

Gastro-oesophageal reflux disease

308

1475

1.86

22.61

1.3

1.2

87.78

90.26

u/l

0.16

267

1293

Injuries to the hip and thigh

224

997

2.07

22.54

1.3

1.2

101.61

90.46

u/l

0.61

199

854

Mood disorders

467

1844

1.67

22.46

1.2

99.85

86.89

u/l

1.39

413

1616

Symptoms and signs involving the digestive system and abdomen

449

1317

1.71

22.40

1.2

103.78

88.80

u/l

1.26

400

1141

Disorders of thyroid, IBD co-morbidities

177

3.48

22.38

1.1

1.3

77.54

102.16

u/l

1.05

160

Type 1 diabetes, strict (exclude DM2)

133

4.31

22.36

1.4

1.2

119.37

94.87

u/l

0.50

116

Type 1 diabetes, definitions combined

133

4.31

22.36

1.4

1.2

119.37

84.99

u/l

0.92

116

Noninfectious colitis NAS

238

3.39

22.35

1.3

1.1

96.00

78.64

u/l

0.59

202

Valvular heart disease excluding rheumatic fever

215

742

2.13

22.31

1.3

1.2

116.39

83.50

u/l

2.70

193

637

Follow-up examination after treatment for conditions other than malignant neoplasms

217

668

2.14

22.23

1.2

87.36

83.93

u/l

0.21

192

576

Vitreous haemorrhage

187

3.74

22.22

1.5

1.2

113.66

87.09

u/l

1.21

160

Mood [affective] disorders

465

1843

1.66

22.18

1.2

99.65

86.75

u/l

1.38

411

1615

Iron deficiency anaemia secondary to blood loss (chronic)

305

3.08

22.15

1.3

1.2

114.35

83.37

u/l

1.32

267

Paralytic ileus and intestinal obstruction

132

522

2.54

22.03

1.4

1.2

110.25

86.67

u/l

1.35

117

442

Dermatitis and eczema

485

1941

1.64

21.99

1.3

1.2

91.15

91.08

u/l

0.00

425

1710

Depression medications

139

3.45

21.95

1.2

98.69

70.35

u/l

1.60

119

Non-rheumatic valve diseases

213

737

2.12

21.90

1.3

1.2

109.94

83.45

u/l

2.78

191

632

Symptoms and signs involving the circulatory and respiratory systems

444

1308

1.71

21.86

1.2

99.55

86.75

u/l

1.30

399

1142

Parasetamol

345

961

1.84

21.85

1.3

1.2

96.84

89.28

u/l

0.48

304

850

Nephrotic syndrome

6.65

21.83

1.3

1.2

84.40

87.02

u/l

0.05

Atrial fibrillation and flutter with reimbursement

140

349

2.59

21.74

1.2

98.14

82.28

u/l

1.12

124

296

Parodontitis

416

1816

1.69

21.68

1.3

1.2

88.34

91.47

u/l

0.28

370

1588

Other gastritis (incl. Duodenitis)

122

469

2.62

21.62

1.2

105.63

90.10

u/l

0.75

107

401

Other diseases of pancreas

129

4.33

21.59

1.3

1.2

97.83

80.61

u/l

0.68

113

Parodontitis or operation codes

416

1817

1.69

21.57

1.3

1.2

88.34

91.43

u/l

0.27

370

1589

Collagenous colitis

160

3.93

21.41

1.3

1.1

109.52

80.95

u/l

1.11

138

Cardiomyopathy

285

3.11

21.40

1.2

115.16

88.09

u/l

1.32

241

Cholecystectomy

340

1704

1.77

21.40

1.2

89.13

90.54

u/l

0.10

299

1491

Pain (limb, back, neck, head abdominally)

321

862

1.87

21.39

1.2

89.42

101.40

u/l

0.77

278

754

Enterocolitis due to Clostridium difficile

188

3.66

21.27

1.3

1.1

114.08

92.08

u/l

0.72

158

Mood disorders, excluding more controls

434

1575

1.68

21.21

1.2

98.98

85.13

u/l

1.55

383

1385

Ulcerative proctitis

5.13

21.20

1.6

1.1

64.72

74.48

u/l

0.49

Asthma (diagnoses ohter than nonallergic)

388

1955

1.70

21.16

1.3

1.2

90.02

89.65

u/l

0.02

340

1717

Disorder of lipoprotein metabolism, unspecified

237

3.32

21.10

1.3

1.2

92.35

93.33

u/l

0.03

198

Primary_lymphoid and hematopoietic malignant neoplasms

126

503

2.52

20.68

1.2

142.00

92.20

u/l

0.89

118

426

Headache

267

1183

1.89

20.67

1.3

1.2

86.22

80.74

u/l

0.40

237

1037

Cerebrovascular diseases (FINNGEN)

152

458

2.39

20.62

1.3

1.2

115.20

84.25

u/l

1.38

130

392

Benign neoplasm: Colon, unspecified

115

438

2.63

20.56

1.2

104.91

89.71

u/l

0.62

376

Cellulitis

114

435

2.64

20.53

1.4

1.2

107.05

83.55

u/l

1.43

106

373

Chronic periodontitis, including avohilmo

410

1819

1.67

20.45

1.3

1.2

88.39

91.30

u/l

0.25

364

1592

Other or unspecified ileus, impaction or obstruction

331

2.89

20.33

1.5

1.2

113.12

89.04

u/l

1.09

277

Benign neoplasms

418

1388

1.69

20.27

1.2

83.07

94.10

u/l

1.63

360

1227

Injuries to the abdomen, lower back, lumbar spine and pelvis

182

852

2.13

20.25

1.3

1.2

95.07

89.80

u/l

0.20

163

724

Hyperlipidaemia, other/unspecified

178

785

2.16

20.22

1.2

101.80

89.70

u/l

0.63

153

675

Use of hypnotics and sedatives

473

1688

1.62

20.08

1.3

1.2

93.72

90.96

u/l

0.19

402

1497

Obesity

273

1472

1.84

20.05

1.2

1.3

79.80

88.56

u/l

1.07

241

1282

Obesity and other hyperalimentation

274

1478

1.84

20.05

1.2

1.3

79.83

88.47

u/l

1.05

242

1288

Total colectomy

5.45

20.01

1.7

1.2

85.94

75.47

u/l

0.30

Total colectomy operation

5.45

20.01

1.7

1.2

85.94

75.47

u/l

0.30

204

1006

2.02

19.68

1.3

1.2

98.86

92.57

u/l

0.30

188

865

Peripheral arterial reconstruction

311

2.92

19.60

1.3

1.2

107.88

94.85

u/l

0.52

262

Other/unspecified seropositive rheumatoid arthritis

153

683

2.26

19.58

1.2

80.81

83.67

u/l

0.19

140

590

Other infectious diseases

139

4.01

19.58

1.2

1.1

109.69

91.74

u/l

0.51

118

Symptoms and signs involving cognition, perception, emotional state and behaviour

428

1837

1.64

19.50

1.2

91.07

92.05

u/l

0.07

366

1626

Other diseases of pleura

205

902

2.02

19.47

1.3

1.2

130.24

92.26

u/l

2.97

187

768

Fracture of lumbar spine and pelvis

111

429

2.60

19.45

1.3

1.2

97.77

92.97

u/l

0.16

364

Seropositive rheumatoid arthritis, wide

155

699

2.23

19.36

1.2

80.11

84.45

u/l

0.31

142

605

Anxiety (asthma-related co-morbidities)

260

1100

1.87

19.23

1.2

1.3

92.39

82.36

u/l

0.56

224

960

Other disorders of urethra and urinary system

315

1340

1.77

19.22

1.2

88.91

87.97

u/l

0.06

279

1172

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

150

671

2.25

19.11

1.2

80.82

83.50

u/l

0.17

137

580

Diabetic retinopathy, strict definition

108

361

2.65

19.08

1.4

1.2

117.20

110.61

u/l

0.23

101

317

Coagulation defects, purpura and other haemorrhagic conditions

102

384

2.68

18.92

1.4

1.2

125.05

89.73

u/l

1.25

330

Enlarged lymph nodes

285

2.97

18.91

1.3

1.2

129.12

79.05

u/l

1.78

250

Diseases of the musculoskeletal system and connective tissue

219

538

2.05

18.90

1.2

1.3

91.89

100.40

u/l

0.37

184

481

Other systemic involvement of connective tissue

148

662

2.25

18.86

1.2

87.55

85.88

u/l

0.08

130

572

Heart failure and coronary heart disease

152

500

2.28

18.81

1.2

1.3

121.04

99.37

u/l

1.27

134

429

Cardiodefibrillation

168

794

2.12

18.57

1.2

1.3

99.82

95.23

u/l

0.24

148

680

Psoriatic and enteropathic arthropathies

196

3.40

18.56

1.2

70.28

90.82

u/l

1.53

171

502

1685

1.58

18.55

1.3

1.2

93.62

87.08

u/l

0.68

454

1471

Obesity, other/unspecified

161

751

2.15

18.49

1.2

80.52

86.51

u/l

0.51

149

653

L02BA Anti-estrogens

109

430

2.56

18.43

1.2

76.00

79.27

u/l

0.13

101

376

Methotrexate

284

2.95

18.43

1.1

74.63

80.13

u/l

0.30

247

Parodontitis and operation codes

384

1815

1.65

18.39

1.3

1.2

88.45

91.22

u/l

0.22

341

1589

Other CVD

350

2.73

18.38

1.4

1.2

77.33

96.50

u/l

1.31

298

Other antidepressants

452

1464

1.61

18.37

1.2

1.3

92.42

92.05

u/l

0.02

389

1292

Diseases of the eye and adnexa

354

1032

1.72

18.15

1.3

1.2

83.47

92.42

u/l

0.93

313

909

Gastroduodenal ulcer

122

509

2.40

18.15

1.2

112.21

99.61

u/l

0.44

109

436

Anxiety disorders, excluding more controls

367

1456

1.68

18.14

1.2

1.3

89.98

82.75

u/l

0.57

321

1273

Hypokalaemia

199

3.35

18.14

1.3

1.1

93.91

89.88

u/l

0.12

168

Benzodiazepine use

435

1941

1.60

18.11

1.2

95.87

90.45

u/l

0.46

375

1713

Benign neoplasm of other and ill-defined parts of digestive system

103

399

2.60

18.08

1.3

1.2

94.66

83.93

u/l

0.65

346

L04AC Interleukin inhibitors

5.15

17.91

1.2

1.1

79.32

82.00

u/l

0.06

Presence of cardiac and vascular implants and grafts

199

756

2.00

17.83

1.2

122.89

90.21

u/l

3.49

178

644

Intestinal stricture

150

691

2.18

17.81

1.3

1.2

105.38

89.99

u/l

0.82

130

584

Viral and other specified intestinal infections

298

2.83

17.76

1.3

1.2

161.81

80.65

u/l

1.06

256

Cough

192

930

1.99

17.71

1.2

104.90

84.39

u/l

0.44

173

805

Other diseases of hard tissues of teeth

268

1109

1.81

17.67

1.2

111.03

89.92

u/l

0.64

241

957

Hypo-osmolality and hyponatraemia

323

2.77

17.63

1.2

107.69

92.06

u/l

0.63

268

Dermatitis

269

1519

1.78

17.61

1.3

1.2

94.53

90.94

u/l

0.23

229

1320

Diabetic retinopathy

178

536

2.11

17.59

1.4

1.2

111.81

107.02

u/l

0.21

156

473

All anxiety disorders

262

1176

1.80

17.27

1.2

92.30

83.45

u/l

0.48

225

1036

Other diseases of stomach and duodenum

112

4.17

17.26

1.3

1.1

98.02

81.84

u/l

0.53

Other diseases of arteries and capillaries

167

3.51

17.16

1.3

1.2

130.94

81.16

u/l

1.38

147

Accidents

366

1095

1.68

17.14

1.3

1.2

94.44

90.10

u/l

0.24

319

968

Acute pancreatitis

381

2.59

17.09

1.2

127.36

83.17

u/l

2.50

326

Other and unspecified dermatitis

228

1239

1.85

16.99

1.2

94.08

90.53

u/l

0.22

198

1073

Symptoms and signs concerning food and fluid intake

149

3.65

16.97

1.2

176.33

80.42

u/l

0.67

126

Other external causes of accidental injury

365

1095

1.67

16.93

1.3

1.2

91.53

90.10

u/l

0.07

319

968

Other disorders of white blood cells

4.56

16.83

1.1

1.2

128.09

79.88

u/l

1.37

Bronchitis

456

1926

1.56

16.73

1.3

1.2

100.75

87.70

u/l

1.27

409

1687

Other disorders of glucose regulation and pancreatic internal secretion

128

3.87

16.69

1.3

1.1

119.63

94.58

u/l

0.78

111

Benign neoplasm: Sigmoid colon

307

2.76

16.56

1.3

1.2

83.31

85.37

u/l

0.08

258

Diabetic neuropathy

241

3.01

16.51

1.3

119.24

105.98

u/l

0.35

208

Other acute lower respiratory infections

223

1171

1.82

15.87

1.3

1.2

105.48

91.12

u/l

0.91

197

1014

Disorders of lens

320

1207

1.68

15.80

1.4

1.2

102.54

88.77

u/l

1.08

293

1043

Neurotic, stress-related and somatoform disorders

381

1703

1.59

15.78

1.2

92.10

87.48

u/l

0.30

334

1495

Anxiety disorders

385

1720

1.59

15.76

1.2

91.43

87.53

u/l

0.25

338

1510

Hypothyroidism, strict autoimmune

262

984

1.77

15.74

1.2

82.03

87.16

u/l

0.50

237

845

Elevated blood glucose level

120

3.87

15.72

1.1

1.2

96.10

87.76

u/l

0.23

105

Vitamin B12 deficiency anaemia

182

3.27

15.68

1.3

1.1

91.04

85.90

u/l

0.18

158

Other respiratory diseases principally affecting the interstitium

339

2.62

15.68

1.1

1.2

105.11

95.09

u/l

0.38

286

Hypotension

291

2.73

15.37

1.4

1.2

81.21

94.96

u/l

0.74

248

Abnormal results of function studies

141

3.58

15.29

1.3

1.1

120.35

78.79

u/l

1.77

122

Operations 2 for CAVS

127

571

2.19

15.20

1.3

1.2

110.03

93.14

u/l

1.24

119

486

Calcific aortic valvular stenosis, diagnosis (helper)

127

571

2.19

15.20

1.3

1.2

110.03

93.14

u/l

1.24

119

486

Calcific aortic valvular stenosis

127

572

2.18

15.14

1.3

1.2

110.03

92.97

u/l

1.26

119

487

Calcific aortic valvular stenosis, operated

127

572

2.18

15.14

1.3

1.2

110.03

92.97

u/l

1.26

119

487

Acute bronchitis

181

930

1.91

15.08

1.3

1.2

107.30

88.87

u/l

1.09

162

800

Calcific aortic valvular stenosis, including rheumatic fever

127

573

2.18

15.04

1.3

1.2

110.03

93.59

u/l

1.19

119

487

Chronic tubulo-interstitial nephritis

4.86

14.98

1.3

1.1

75.43

68.49

u/l

0.29

Idiopathic gout

139

3.56

14.87

1.4

1.3

114.93

96.59

u/l

0.44

119

Depression or dysthymia

311

1043

1.67

14.87

1.2

1.3

104.93

88.74

u/l

1.26

271

919

Hypertensive Heart Disease

100

337

2.44

14.84

1.2

1.3

119.28

92.20

u/l

1.31

286

Invasive ventilation

121

3.76

14.77

1.2

1.1

215.85

93.00

u/l

0.73

105

Conduction disorders

121

453

2.23

14.73

1.2

103.66

85.82

u/l

1.22

113

381

Irritable bowel syndrome

125

579

2.17

14.73

1.2

87.26

82.10

u/l

0.21

110

502

Other/unspecified dorsalgia

168

863

1.94

14.72

1.2

87.39

89.56

u/l

0.10

141

743

Asthma, including avohilmo

491

1913

1.49

14.69

1.3

1.2

93.07

93.25

u/l

0.01

433

1686

Abnormalities of gait and mobility

232

2.92

14.67

1.2

122.79

86.91

u/l

0.75

202

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

160

815

1.97

14.61

1.2

80.07

87.39

u/l

0.43

141

706

Syncope and collapse

176

816

1.92

14.52

1.3

1.2

110.66

84.04

u/l

1.87

150

706

Other dorsopathies, not elsewhere classified

418

1426

1.55

14.49

1.2

90.23

90.71

u/l

0.03

367

1257

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

122

541

2.18

14.43

1.3

1.2

63.80

79.16

u/l

1.71

111

474

Hypoglycaemia, other or unspecified

105

3.95

14.40

1.3

1.1

125.74

91.53

u/l

1.04

Other joint disorders

346

1145

1.61

14.24

1.2

1.3

79.21

96.25

u/l

3.10

299

1012

Acute pancreatitis (for exclusion)

417

2.37

14.17

1.2

127.36

88.61

u/l

1.99

352

Paroxysmal tachycardia

342

2.41

14.15

1.4

1.2

95.69

83.10

u/l

0.53

296

Diagnoses used for exclusion with ILD

123

576

2.15

14.13

1.2

100.61

94.17

u/l

0.37

110

488

Injuries to the head

452

1967

1.50

14.09

1.2

101.66

90.80

u/l

0.99

382

1747

Falls/tendency to fall

454

1503

1.52

14.09

1.3

1.2

96.64

88.70

u/l

0.64

395

1323

Other anxiety disorders

186

892

1.85

13.90

1.2

84.99

80.64

u/l

0.23

158

790

Chronic lower respiratory diseases

500

1841

1.47

13.72

1.3

1.2

101.86

90.56

u/l

1.01

443

1622

Complications of internal orthopaedic prosthetic devices, implants and grafts

108

486

2.24

13.72

1.3

1.2

101.61

89.40

u/l

0.49

409

Soft tissue disorders

418

1423

1.53

13.64

1.3

1.2

85.34

94.27

u/l

0.98

366

1253

Genitourinary diseases

228

639

1.79

13.57

1.2

106.10

90.22

u/l

0.78

199

551

Fracture of lower leg, including ankle

239

1404

1.70

13.55

1.2

93.60

89.37

u/l

0.25

218

1211

Persons encountering health services for examination and investigation

262

766

1.72

13.52

1.2

95.87

86.17

u/l

0.65

230

662

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

408

1756

1.52

13.43

1.3

1.2

98.63

92.04

u/l

0.63

358

1537

Sequelae of external causes of morbidity and mortality

121

576

2.11

13.36

1.2

84.14

89.71

u/l

0.28

104

496

Myocardial infarction, without ST-elevation

165

805

1.90

13.35

1.2

1.3

115.46

94.52

u/l

1.28

146

683

Symptoms and signs involving the skin and subcutaneous tissue

288

1781

1.61

13.33

1.2

85.06

90.57

u/l

0.51

259

1548

Malignant neoplasm of breast, HER-negative

113

524

2.17

13.32

1.3

1.2

64.63

82.34

u/l

1.93

102

453

Benign neoplasm: Colon, unspecified

115

538

2.15

13.29

1.2

104.91

92.16

u/l

0.48

461

Valvular operations

223

2.84

13.27

1.4

1.2

164.60

89.95

u/l

1.91

191

Seropositive rheumatoid arthritis, strict definition

350

2.45

13.27

1.2

72.50

87.43

u/l

1.27

306

Exposure to other specified factors

293

1714

1.61

13.23

1.3

1.2

86.55

90.18

u/l

0.26

260

1494

Other cataract

201

870

1.80

13.22

1.3

1.2

101.56

87.27

u/l

0.81

180

742

Colectomy operation

351

2.44

13.18

1.4

1.2

115.20

89.81

u/l

0.91

305

Abnormal weight loss

146

3.32

13.12

1.2

101.74

83.95

u/l

0.86

127

Fracture of rib(s), sternum and thoracic spine

125

607

2.07

13.09

1.3

1.2

89.11

94.06

u/l

0.22

108

508

Open wound of lower leg

270

2.65

13.06

1.4

1.1

132.74

87.41

u/l

1.13

231

Diseases of the respiratory system

280

842

1.67

13.04

1.2

95.11

78.55

u/l

2.04

254

728

External causes of morbidity and mortality

286

865

1.66

13.04

1.2

99.29

90.42

u/l

0.44

245

766

Acute upper respiratory infections of multiple and unspecified sites

300

1406

1.60

12.93

1.3

1.2

99.16

88.04

u/l

0.70

274

1213

Hernia

393

1767

1.51

12.89

1.3

1.2

92.34

90.75

u/l

0.09

340

1553

Overexertion and strenuous or repetitive movements

184

3.02

12.84

1.3

1.1

98.13

82.96

u/l

0.44

156

Injuries to the thorax

183

1019

1.80

12.74

1.2

87.71

94.65

u/l

0.50

163

875

Trigger finger

333

2.45

12.70

1.3

1.2

86.81

81.93

u/l

0.22

295

Asthma, hospital admissions , main diagnosis only

340

1987

1.54

12.56

1.3

1.2

92.04

91.46

u/l

0.03

303

1742

Other arrhythmias

251

1164

1.66

12.38

1.2

95.53

84.11

u/l

0.73

221

1007

Osteoporosis with pathological fracture (FG)

127

3.43

12.34

1.2

1.1

97.33

75.61

u/l

0.73

112

Mycoses

120

588

2.05

12.31

1.4

1.2

103.74

86.89

u/l

1.10

110

502

Cardiomyopathy (excluding other)

194

2.91

12.30

1.2

131.86

88.04

u/l

1.78

160

Gastric ulcer

314

2.47

12.28

1.2

1.1

122.37

96.32

u/l

0.74

268

Recurrent or chronic depression

173

681

1.84

12.23

1.2

1.3

99.23

83.24

u/l

0.70

150

605

Cardiomyopathies, Primary/intrinsic

185

2.94

12.11

1.2

133.67

86.43

u/l

1.96

155

Need for other prophylactic measures

3.89

12.10

1.1

1.2

82.43

76.40

u/l

0.19

Other disorders of teeth and supporting structures

410

2.26

12.02

1.3

1.2

98.26

86.75

u/l

0.57

342

Other special examinations and investigations of persons without complaint or reported diagnosis

253

766

1.67

12.00

1.3

1.2

98.03

86.17

u/l

0.68

224

662

Benign neoplasm: Transverse colon

155

3.12

11.93

1.3

1.1

99.67

84.31

u/l

0.44

132

Personality disorders, excluding more controls

106

502

2.12

11.90

1.1

1.2

95.65

78.17

u/l

0.90

446

Intestinal malabsorption

4.11

11.87

1.4

1.2

151.81

76.03

u/l

1.85

Sciatica+with lumbago

211

1184

1.70

11.86

1.3

1.2

91.37

88.99

u/l

0.12

181

1032

Lichen simplex chronicus and prurigo

111

3.55

11.85

1.3

1.1

87.84

80.03

u/l

0.31

Retention of urine

127

539

2.00

11.83

1.3

111.84

96.02

u/l

0.88

115

462

Dizziness and giddiness

309

1620

1.55

11.83

1.2

90.93

91.05

u/l

0.01

260

1429

Amiodarone users

188

2.90

11.79

1.1

1.3

105.27

94.59

u/l

0.35

160

Hard cardiovascular diseases

333

1393

1.54

11.75

1.2

102.65

88.10

u/l

1.16

288

1212

Other reaction to severe stress, and adjustment disorders

150

808

1.86

11.68

1.3

1.2

96.65

81.63

u/l

0.61

137

712

Dorsopathies

414

1433

1.48

11.54

1.2

86.07

90.37

u/l

0.34

366

1264

Alcohol use disorder, Swedish definition

212

1174

1.68

11.49

1.2

1.3

117.36

95.46

u/l

1.40

177

1034

Injuries to the knee and lower leg

480

1929

1.43

11.45

1.3

1.2

96.46

89.67

u/l

0.60

428

1691

222

1233

1.66

11.40

1.2

1.3

115.19

95.43

u/l

1.29

187

1090

Papulosquamous disorders

173

982

1.77

11.37

1.2

94.17

86.80

u/l

0.42

155

841

Persons with potential health hazards related to communicable diseases

143

760

1.87

11.32

1.3

1.2

109.83

91.55

u/l

0.57

129

676

Other (not insulin) diabetes medications

390

1596

1.48

11.23

1.2

101.02

85.65

u/l

1.74

343

1396

Symptoms and signs involving the urinary system

310

1565

1.53

11.23

1.3

1.2

95.89

89.98

u/l

0.41

271

1364

Weight loss

167

2.96

11.13

1.2

101.42

82.12

u/l

1.04

145

Other medical care

157

851

1.81

11.09

1.5

1.2

123.92

89.54

u/l

2.68

148

728

Myocardial infarction

210

897

1.69

11.03

1.3

109.86

90.98

u/l

1.40

183

772

In situ neoplasms

136

689

1.89

11.01

1.2

101.13

84.53

u/l

1.12

126

601

Exclusions for E4_PCOS_BROAD

337

2.33

10.99

1.3

1.2

85.69

95.07

u/l

0.39

292

Psoriasis

131

690

1.91

10.98

1.2

1.3

93.85

89.25

u/l

0.19

117

595

Tubulo-interstitial nephritis, not specified as acute or chronic

107

3.49

10.98

1.2

106.75

80.08

u/l

0.92

Neurological diseases, wide definition

222

2.24

10.92

1.2

1.3

89.18

121.46

u/l

0.80

203

Benign neoplasm: Sigmoid colon

378

2.24

10.79

1.3

1.2

83.31

84.91

u/l

0.06

330

Parodontitis or/and operation codes

271

1022

1.58

10.67

1.3

90.33

92.13

u/l

0.10

238

901

Sequelae with surgical and medical care as external cause

425

2.15

10.66

1.3

1.2

82.92

89.46

u/l

0.29

368

Obesity due to excess calories

179

1047

1.72

10.61

1.2

1.3

76.22

86.33

u/l

1.02

156

910

Opening and dilatation of root channel of tooth

100

3.53

10.59

1.2

102.24

82.60

u/l

0.45

Factors influencing health status and contact with health services

119

292

2.05

10.57

1.1

96.93

76.79

u/l

1.09

101

252

Abnormal findings on diagnostic imaging of lung

196

1145

1.67

10.54

1.2

100.31

89.87

u/l

0.66

171

993

Seronegative rheumatoid arthritis

223

2.62

10.53

1.2

1.1

87.41

84.58

u/l

0.08

191

ILD, hospital admissions

283

2.42

10.46

1.1

1.2

95.79

88.62

u/l

0.27

242

Early onset COPD, excluding more controls

370

2.23

10.44

1.1

1.2

115.10

75.31

u/l

1.95

311

Spondylosis

221

1170

1.62

10.42

1.2

86.94

92.32

u/l

0.35

189

1020

Any mental disorder

457

1614

1.42

10.40

1.2

99.20

89.36

u/l

0.74

398

1422

Other interstitial pulmonary diseases

284

2.41

10.39

1.1

1.2

95.79

91.99

u/l

0.12

241

Interstitial lung disease endpoints

285

2.40

10.31

1.1

1.2

95.79

92.56

u/l

0.10

243

Interstitial lung disease

285

2.40

10.31

1.1

1.2

95.79

92.56

u/l

0.10

243

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

293

2.36

10.28

1.4

1.2

114.71

90.46

u/l

0.50

255

Injuries to the ankle and foot

259

1521

1.55

10.25

1.4

1.2

94.07

85.68

u/l

0.70

231

1329

Venous thromboembolism

225

1367

1.60

10.23

1.3

1.2

98.96

91.52

u/l

0.60

202

1186

Other (seronegative) rheumatoid arthritis, wide

466

2.07

10.20

1.2

94.26

86.15

u/l

0.36

399

Senile cataract

275

1100

1.55

10.19

1.3

1.2

98.83

87.69

u/l

0.85

251

946

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

433

2.11

10.18

1.8

1.2

111.42

88.32

u/l

0.89

371

228

1281

1.60

10.14

1.2

1.3

113.58

95.21

u/l

1.19

192

1133

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

157

784

1.76

10.11

1.6

1.2

120.71

86.08

u/l

2.56

143

675

Unspecified haematuria

159

778

1.76

10.04

1.2

115.91

93.04

u/l

1.55

142

666

Benign neoplasm: Rectum, anus and anal canal

345

2.24

10.02

1.2

106.00

87.43

u/l

0.62

291

STROKE

234

1018

1.60

10.00

1.2

105.71

81.93

u/l

1.58

202

878

Congenital malformations, deformations and chromosomal abnormalities

223

1344

1.59

9.91

1.3

1.2

86.64

87.01

u/l

0.02

194

1180

Macular pucker

297

2.34

9.88

1.3

1.2

109.18

84.60

u/l

0.94

258

Intracranial trauma

225

1051

1.60

9.87

1.2

111.71

91.93

u/l

1.26

195

935

Diseases of pulp and periapical tissues, including avohilmo

432

1585

1.42

9.86

1.2

90.83

92.03

u/l

0.08

367

1398

Dental pulpitis 4

433

1590

1.42

9.84

1.2

90.13

92.04

u/l

0.13

369

1402

Chronic rhinitis, nasopharyngitis and pharyngitis

141

790

1.79

9.77

1.3

1.2

83.67

90.11

u/l

0.34

121

682

Disorders of synovium and tendon

210

1175

1.61

9.76

1.3

78.83

89.41

u/l

1.27

190

1027

COPD (mode)

117

485

1.92

9.71

1.1

1.2

117.23

77.19

u/l

2.61

411

Non-selective monoamine reuptake inhibitors

171

982

1.69

9.71

1.1

1.3

91.70

88.32

u/l

0.16

150

852

Other local infections of skin and subcutaneous tissue

175

2.76

9.69

1.4

1.1

110.72

88.34

u/l

0.63

149

Misadventures to patients during surgical and medical care

281

2.36

9.69

1.3

1.1

122.15

80.87

u/l

1.41

245

Dental pulpitis 1

432

1591

1.41

9.68

1.2

90.27

92.00

u/l

0.12

368

1403

Myocardial infarction, strict

189

830

1.67

9.62

1.2

1.3

109.81

93.05

u/l

1.04

165

710

Dental caries, including avohilmo

317

1083

1.50

9.61

1.2

98.55

87.62

u/l

0.81

272

956

Dental caries 1

317

1083

1.50

9.60

1.2

98.55

87.62

u/l

0.81

272

956

Nerve, nerve root and plexus disorders

419

1872

1.41

9.58

1.3

1.2

86.13

93.45

u/l

0.89

371

1640

Other and unspecified local infections of skin and subcutaneous tissue

160

2.83

9.52

1.4

1.1

110.82

88.87

u/l

0.59

138

Urticaria and erythema

151

872

1.74

9.44

1.2

95.80

84.85

u/l

0.42

137

756

Psychiatric diseases

441

1577

1.40

9.42

1.2

99.87

89.55

u/l

0.76

386

1384

Benign neoplasm: Rectum

310

2.27

9.39

1.3

1.2

100.05

85.27

u/l

0.54

263

Benign neoplasm: Ascending colon

213

2.55

9.35

1.2

113.18

81.44

u/l

1.04

183

Benign neoplasm of other and unspecified endocrine glands

231

2.48

9.33

1.4

1.1

78.98

81.52

u/l

0.09

199

Fall involving bed

4.74

9.32

1.1

1.2

122.69

72.08

u/l

1.03

Conjunctivitis

295

1739

1.48

9.31

1.2

76.75

86.83

u/l

1.17

264

1522

Duodenal ulcer

179

2.70

9.29

1.2

1.1

92.56

94.98

u/l

0.06

149

Other intervertebral disc disorders

321

1338

1.47

9.24

1.2

87.92

92.21

u/l

0.29

271

1175

Type 2 diabetes, definitions combined

367

1529

1.43

9.23

1.2

97.34

85.54

u/l

1.33

321

1336

Persistent mood disorders

430

2.06

9.23

1.1

1.2

89.55

84.08

u/l

0.20

369

Substance abuse, excluding more controls

204

1116

1.60

9.22

1.2

1.3

115.18

88.43

u/l

2.01

172

981

Pruritus

203

2.58

9.20

1.2

1.1

91.26

80.63

u/l

0.35

174

Degeneration of macula and posterior pole

186

936

1.64

9.20

1.3

1.2

95.70

92.03

u/l

0.19

154

818

Convulsions, not elsewhere classified

380

2.11

9.11

1.1

1.2

118.19

81.10

u/l

1.40

325

Cyst of kidney

121

3.09

9.09

1.2

1.1

67.88

90.73

u/l

1.45

106

Superficial injury of head

453

2.02

9.06

1.2

103.07

80.79

u/l

1.42

394

Disorders of sclera, cornea, iris and ciliary body

210

1335

1.58

9.04

1.3

1.2

102.86

87.78

u/l

1.30

196

1148

Melanocytic naevi

106

558

1.91

8.99

1.3

1.2

86.95

86.50

u/l

0.02

479

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

161

742

1.70

8.92

1.2

158.96

86.78

u/l

1.97

142

638

Benign neoplasm: Adrenal gland

123

3.04

8.85

1.3

1.1

84.53

82.45

u/l

0.05

106

ILD, hospital admissions 1, main diag only

262

2.34

8.82

1.1

1.2

97.43

86.74

u/l

0.41

224

Candidiasis

256

2.36

8.80

1.5

1.2

115.04

79.62

u/l

2.10

224

Disorders of conjunctiva

317

1841

1.44

8.77

1.2

77.75

88.67

u/l

1.41

284

1610

Type 2 diabetes, strict (exclude DM1)

367

1545

1.42

8.77

1.2

97.27

85.50

u/l

1.32

321

1349

Acute upper respiratory infections

413

1868

1.39

8.70

1.3

1.2

90.29

88.04

u/l

0.18

377

1626

Major coronary heart disease event excluding revascularizations

260

1192

1.51

8.69

1.2

102.47

91.19

u/l

0.89

228

1030

Behavioural syndromes associated with physiological disturbances and physical factors

119

659

1.81

8.61

1.2

80.64

84.04

u/l

0.16

105

577

Other/unspecified rheumatoid arthritis

265

2.32

8.61

1.2

1.1

87.57

80.68

u/l

0.32

230

Selective serotonin reuptake inhibitors

391

1467

1.41

8.59

1.2

1.3

95.68

91.99

u/l

0.24

338

1295

Unspecified fall

188

1170

1.60

8.58

1.2

95.12

91.19

u/l

0.15

170

1015

Other diseases of pericardium

4.08

8.53

1.4

1.2

161.13

91.96

u/l

1.12

Phobic anxiety disorders

199

2.52

8.52

1.1

1.2

101.02

90.63

u/l

0.26

174

Chronic sinusitis

174

1074

1.62

8.49

1.4

1.2

79.28

88.31

u/l

0.79

160

925

Dental caries 1 and operation codes

343

1228

1.44

8.43

1.2

98.23

90.02

u/l

0.58

293

1082

Disorders of skin appendages

179

1116

1.61

8.39

1.3

1.2

85.74

86.61

u/l

0.04

155

971

Type 2 diabetes, definitions combined, including avohilmo

365

1535

1.41

8.38

1.2

97.16

85.02

u/l

1.37

315

1342

Fracture of shoulder and upper arm

147

873

1.69

8.35

1.3

1.2

98.53

86.05

u/l

0.71

128

751

Erosion of teeth, including avohilmo

308

2.17

8.34

1.2

1.3

93.26

86.43

u/l

0.22

269

Ischaemic heart disease, wide definition

318

1384

1.44

8.31

1.2

97.82

88.53

u/l

0.84

279

1202

Glucagon-like peptide-1 (GLP-1) analogues

227

1225

1.53

8.31

1.2

108.04

87.93

u/l

2.02

196

1065

Personality disorders

106

575

1.85

8.24

1.1

1.2

95.65

82.68

u/l

0.59

504

Sleep disorders (combined)

388

1840

1.38

8.17

1.2

78.74

93.60

u/l

2.84

341

1612

Disorders of adult personality and behaviour

110

606

1.82

8.14

1.1

1.2

94.74

82.62

u/l

0.56

532

Major coronary heart disease event

279

1271

1.47

8.13

1.2

102.50

91.25

u/l

0.94

245

1096

Non-allergic asthma (mode), excluding more controls

346

2.10

8.13

1.3

1.2

106.10

66.60

u/l

1.55

295

Other diseases of anus and rectum

115

642

1.80

8.12

1.4

1.2

104.01

84.13

u/l

1.19

100

551

Functional dyspepsia

107

585

1.84

8.12

1.2

86.45

85.01

u/l

0.05

509

Thyrotoxicosis, other and/or unspecified

445

1.96

8.09

1.1

1.2

79.51

86.05

u/l

0.24

391

Dental caries 3

328

1174

1.43

7.95

1.2

100.63

88.84

u/l

0.90

278

1039

Acute sinusitis

193

1156

1.56

7.92

1.3

1.2

89.79

85.59

u/l

0.28

181

1002

Pacemaker

120

665

1.76

7.90

1.2

113.84

98.00

u/l

0.88

110

565

Inflammatory diseases of the central nervous system

137

2.79

7.90

1.2

1.1

93.59

88.53

u/l

0.11

119

Concussion

181

990

1.59

7.89

1.2

111.18

91.70

u/l

1.00

156

879

Pulmonary heart disease, diseases of pulmonary circulation

127

737

1.73

7.89

1.3

1.2

106.52

91.12

u/l

0.89

112

627

Thyrotoxicosis

109

607

1.80

7.82

1.1

1.2

76.43

84.35

u/l

0.38

533

malignant neoplasm of male genital organs

129

468

1.76

7.80

1.6

1.2

107.63

110.28

u/l

0.07

116

399

Nonorganic sleeping disorders, excluding more controls

342

2.08

7.80

1.2

79.13

81.70

u/l

0.09

300

Urticaria

121

698

1.74

7.70

1.2

95.48

85.07

u/l

0.33

109

614

Other specified/unspecified bacterial intestinal infections

112

2.97

7.66

1.2

83.79

82.40

u/l

0.04

Spinal stenosis

203

1037

1.54

7.63

1.2

84.54

91.21

u/l

0.45

173

900

Dipeptidyl peptidase 4 (DPP-4) inhibitors

229

2.33

7.62

1.2

127.19

81.97

u/l

1.16

200

Disorders of vitreous body and globe

207

1335

1.52

7.54

1.3

1.2

84.21

87.74

u/l

0.26

183

1155

Disorders of vitreous body

203

1311

1.52

7.48

1.3

1.2

84.15

87.71

u/l

0.25

181

1134

Allergic asthma (mode), excluding more controls

415

1.94

7.45

1.3

1.2

84.53

71.09

u/l

0.72

354

Malignant neoplasm of prostate

125

455

1.74

7.35

1.7

1.2

105.73

108.19

u/l

0.07

112

387

Mental and behavioural disorders due to psychoactive substance use

211

1328

1.50

7.34

1.2

1.3

112.15

93.63

u/l

1.18

179

1169

Benign neoplasm: Transverse colon

202

2.39

7.34

1.3

1.2

99.67

88.22

u/l

0.31

176

Polymyalgia rheumatica

246

2.25

7.31

1.1

1.2

71.79

85.06

u/l

0.68

214

Multiple myeloma, excluding all cancers (controls excluding all cancers)

3.63

7.31

1.4

1.1

143.83

82.31

u/l

1.13

Asthma/COPD (KELA code 203)

357

1836

1.37

7.29

1.3

1.2

97.99

89.81

u/l

0.66

313

1617

Obesity related asthma

133

800

1.67

7.29

1.3

1.2

87.28

85.34

u/l

0.08

117

690

Other arthrosis

196

914

1.54

7.28

1.2

1.3

89.87

97.86

u/l

0.53

179

796

Dental caries 3 and operation codes

352

1303

1.39

7.26

1.2

99.28

90.46

u/l

0.64

296

1150

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

210

1382

1.50

7.23

1.2

73.66

86.92

u/l

1.55

189

1215

Missing teeth due to accident, extraction or parodontitis

210

2.35

7.19

1.3

106.86

88.46

u/l

0.60

184

Arterial embolism and thrombosis

100

3.02

7.19

1.2

75.56

99.85

u/l

0.79

Substance abuse

204

1298

1.50

7.19

1.2

1.3

115.18

93.56

u/l

1.42

172

1141

Ankylosing spondylitis, ICD10

156

2.58

7.18

1.1

91.70

86.30

u/l

0.11

134

Cerebral palsy and other paralytic syndromes

211

2.34

7.12

1.4

1.1

98.66

84.33

u/l

0.66

180

Benign neoplasm of other and unspecified endocrine glands

262

2.19

7.11

1.4

1.1

78.98

83.37

u/l

0.17

230

Allergic conjunctivitis

217

1445

1.48

7.10

1.2

73.97

87.34

u/l

1.61

193

1273

Hypothyroidism, other/unspecified

341

1636

1.38

7.08

1.2

82.81

93.29

u/l

1.39

308

1427

Disorders of continuity of bone

181

2.45

7.08

1.2

1.1

78.85

82.45

u/l

0.14

159

Dysphagia

517

1.83

7.07

1.4

1.2

127.88

79.25

u/l

1.30

433

Visual disturbances and blindness

191

1261

1.52

7.06

1.2

94.65

90.09

u/l

0.18

170

1091

Hypothyreosis and Thyroxine purchase for inclusion criteria

355

1716

1.37

7.03

1.2

82.93

92.22

u/l

1.21

321

1494

Fall on same level involving ice and snow

215

1459

1.48

6.96

1.2

96.04

88.39

u/l

0.48

195

1261

Panic disorder

245

2.21

6.95

1.3

1.2

88.56

81.94

u/l

0.23

214

Ischemic heart diseases

312

1402

1.40

6.94

1.2

97.95

88.74

u/l

0.82

276

1217

Calculus of kidney and ureter

110

638

1.73

6.92

1.3

88.64

96.37

u/l

0.39

543

Delirium, not induced by alcohol and other psychoactive substances

195

2.37

6.91

1.1

1.2

85.78

93.88

u/l

0.30

165

Disorders of the thyroid gland

359

1727

1.36

6.89

1.2

81.70

94.25

u/l

1.90

319

1506

Stroke, excluding SAH

229

1162

1.47

6.88

1.2

109.81

89.99

u/l

1.04

196

1014

Pneumonia due to other infectious organisms, not elsewhere classified

4.14

6.83

1.1

1.2

88.28

75.33

u/l

0.36

Benign neoplasm: Adrenal gland

143

2.61

6.79

1.3

1.2

84.53

81.09

u/l

0.09

124

Disorders of tooth development and eruption

3.67

6.78

1.4

1.2

305.71

68.71

u/l

0.69

Other embolism and thrombosis

255

2.17

6.73

1.2

94.59

86.21

u/l

0.31

218

Postmenopausal osteoporosis with pathological fracture

116

2.79

6.65

1.2

94.08

71.71

u/l

0.60

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

294

1.86

6.64

1.8

1.2

106.80

102.24

u/l

0.10

249

Non-allergic asthma (mode)

374

1.94

6.64

1.3

1.2

106.10

72.00

u/l

1.24

317

Transport accidents

153

863

1.57

6.60

1.3

1.2

93.53

84.65

u/l

0.54

128

755

Neurological diseases

337

1236

1.37

6.59

1.2

88.97

97.37

u/l

0.59

291

1101

Other symptoms and signs involving cognitive functions and awareness

167

1020

1.54

6.56

1.2

88.44

90.38

u/l

0.10

144

897

Molar incisor enamel hypoplasia

4.95

6.53

1.7

1.1

439.93

64.04

u/l

0.73

Lung cancer and mesothelioma

287

2.00

6.52

1.2

109.32

84.89

u/l

0.77

242

Subjective visual disturbances

561

1.75

6.49

1.2

85.40

86.87

u/l

0.06

484

Visual disturbances

176

1165

1.51

6.48

1.2

95.72

87.13

u/l

0.36

155

1008

Abnormalities of heart beat

129

788

1.63

6.47

1.2

1.3

93.83

80.27

u/l

0.84

115

678

Psoriasis vulgaris

410

1.89

6.45

1.1

1.2

102.28

91.50

u/l

0.32

350

Nonorganic sleeping disorders

368

1.94

6.45

1.2

79.13

88.11

u/l

0.37

320

Other disorders of bone

396

1.90

6.45

1.2

1.1

83.28

80.93

u/l

0.10

348

Hydronephrosis

177

2.39

6.44

1.3

1.2

82.89

81.16

u/l

0.04

148

Multiple myeloma and malignant plasma cell neoplasms

3.42

6.42

1.4

1.1

129.50

82.46

u/l

0.85

Coronary atherosclerosis

264

1206

1.41

6.40

1.2

100.15

89.60

u/l

0.80

229

1039

Dental pulpitis 2

269

972

1.42

6.37

1.2

100.47

89.38

u/l

0.70

234

854

Exclusions for E4_PCOS_CONSORTIUM

285

1283

1.39

6.36

1.3

1.2

84.21

84.74

u/l

0.04

253

1126

Calcinosis cutis

+∞

6.35

1.8

0.0

64.33

—

u/l

—

Urolithiasis

115

693

1.66

6.32

1.3

86.17

95.50

u/l

0.53

595

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

305

1.83

6.31

1.8

1.2

110.68

103.40

u/l

0.17

255

Allergic asthma (mode)

440

1.83

6.31

1.3

1.2

84.53

72.07

u/l

0.66

375

Injury, poisoning and certain other consequences of external causes

213

721

1.48

6.31

1.2

97.05

90.45

u/l

0.27

182

644

Ankylosing spondylitis

167

2.41

6.27

1.1

1.2

91.70

88.44

u/l

0.06

133

Dental pulpitis 4, only avohilmo

421

1672

1.32

6.26

1.2

90.94

91.99

u/l

0.07

357

1481

Other viral diseases

100

582

1.72

6.19

1.2

91.63

93.44

u/l

0.06

509

Dental pulpitis 2, only avohilmo

273

994

1.41

6.19

1.2

100.64

88.82

u/l

0.77

234

875

Sleep disorders

445

1.83

6.17

1.2

76.46

88.38

u/l

0.63

387

Carbimazole or st.post thyroidectomy, condition for graves disease

489

1.79

6.16

1.1

1.2

73.97

81.77

u/l

0.28

433

Unspecified acute lower respiratory infection

260

2.09

6.04

1.2

115.37

84.81

u/l

1.33

217

Benign neoplasm: Rectum

370

1.90

6.03

1.3

1.2

100.05

84.20

u/l

0.61

318

Coxarthrosis [arthrosis of hip](FG)

198

977

1.47

6.02

1.2

85.32

93.57

u/l

0.60

177

851

Cerebrovascular diseases

279

1451

1.38

6.01

1.3

1.2

111.79

89.08

u/l

1.59

237

1268

Substance use, excluding alcohol

371

1.89

5.98

1.2

101.93

91.56

u/l

0.45

323

Procreative management

123

642

1.62

5.96

1.3

1.2

94.78

95.28

u/l

0.01

113

572

Open wound of head

176

1169

1.49

5.94

1.2

97.97

91.35

u/l

0.36

150

1023

Arthrosis

255

996

1.41

5.94

1.2

1.3

84.05

99.34

u/l

1.56

225

873

Soft tissue disorders related to use, overuse and pressure

106

637

1.67

5.92

1.2

72.68

91.73

u/l

2.06

546

Retinal detachments and breaks

131

830

1.58

5.92

1.2

1.3

94.31

90.51

u/l

0.18

111

723

Monoamine oxidase A inhibitors

269

2.06

5.92

1.2

91.02

84.18

u/l

0.30

237

Dental caries 1, only avohilmo

312

1171

1.36

5.91

1.2

98.72

91.61

u/l

0.44

266

1039

Shoulder lesions

282

1254

1.38

5.90

1.2

88.10

95.16

u/l

0.58

241

1096

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

167

760

1.52

5.87

1.2

99.58

86.64

u/l

0.74

144

654

Degenerative macular diseases

224

2.15

5.83

1.2

85.28

89.48

u/l

0.15

199

Diseases of salivary glands

390

1.85

5.77

1.2

83.54

87.23

u/l

0.15

332

Generalized anxiety disorder

265

2.05

5.76

1.1

1.2

70.09

84.05

u/l

0.82

232

Benign neoplasm: Ascending colon

266

2.04

5.71

1.2

113.18

87.14

u/l

0.79

235

Other and unspecified urticaria

413

1.82

5.71

1.2

98.03

84.63

u/l

0.26

362

Psoriatic arthropathies

181

2.28

5.70

1.2

67.81

87.69

u/l

1.35

158

Memory loss

175

2.30

5.69

1.2

114.41

91.72

u/l

0.48

149

Biguanides

363

1701

1.32

5.65

1.2

105.01

88.54

u/l

1.80

319

1488

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

369

1.80

5.63

1.2

110.01

94.03

u/l

0.48

314

DVT of lower extremities and pulmonary embolism

157

1045

1.50

5.61

1.3

1.2

93.95

91.08

u/l

0.16

146

894

Benign neoplasm: Rectum, anus and anal canal

430

1.80

5.61

1.2

106.00

85.47

u/l

0.73

369

Polyuria

438

1.79

5.58

1.4

1.2

115.69

89.65

u/l

0.72

372

Myeloproliferative diseases

158

2.36

5.56

1.3

1.1

103.53

82.14

u/l

0.50

139

Mental and behavioural disorders due to alcohol

171

1132

1.47

5.56

1.1

1.3

114.06

95.32

u/l

0.93

144

997

Dental pulpitis 1, only avohilmo

417

1685

1.29

5.54

1.2

89.30

92.41

u/l

0.23

354

1493

Retinal vascular disorders

229

2.11

5.53

1.2

107.76

101.07

u/l

0.15

200

Sequelae of injuries of lower limb

184

2.24

5.50

1.2

92.89

82.97

u/l

0.23

157

Intracranial injury

194

1309

1.43

5.49

1.2

110.23

86.32

u/l

1.57

166

1154

Episodal and paroxysmal disorders

425

1691

1.29

5.49

1.2

90.65

95.58

u/l

0.38

361

1494

Vitamin deficiency, wide

2.92

5.47

1.5

1.1

90.25

74.22

u/l

0.34

Vitamin deficiency

2.92

5.47

1.5

1.1

90.25

74.22

u/l

0.34

Acquired haemolytic anaemia

4.00

5.46

1.3

1.2

125.47

76.45

u/l

1.65

Pulmonary embolism

108

669

1.62

5.39

1.3

1.2

99.19

92.22

u/l

0.31

567

Anaemia in chronic diseases classified elsewhere

4.17

5.37

1.4

1.2

108.14

92.86

u/l

0.15

Use of pramipexole

533

1.70

5.36

1.3

1.2

75.62

89.11

u/l

0.77

459

Deforming dorsopathies

108

671

1.61

5.34

1.3

1.2

75.01

83.47

u/l

0.62

100

579

Leiomyoma of uterus

174

663

1.48

5.34

1.3

1.2

80.85

84.23

u/l

0.22

155

577

Infection due to other mycobacteria

5.64

5.34

1.9

1.2

158.00

70.85

u/l

—

Other disorders of veins

154

1036

1.49

5.32

1.2

87.75

83.97

u/l

0.24

130

898

Mental and behavioural disorders due to alcohol, excluding acute intoxication

148

988

1.50

5.29

1.2

1.3

116.19

96.34

u/l

0.91

123

860

Cystic fibrosis with pulmonary manifestations

+∞

5.29

2.6

0.0

177.20

—

u/l

—

Dental operations

249

922

1.39

5.29

1.2

111.33

93.03

u/l

1.21

213

804

Retinal vascular occlusion

227

2.08

5.27

1.2

108.29

98.78

u/l

0.22

198

Keratitis

125

807

1.55

5.26

1.4

1.2

99.84

88.55

u/l

0.57

116

692

COPD, hospital admissions 3, with asthma pneumonia sepsis

479

1.67

5.23

1.2

114.76

98.72

u/l

0.63

411

In situ neoplasms

136

896

1.52

5.22

1.2

101.13

85.49

u/l

1.03

126

775

Other diseases of jaws

108

2.61

5.22

1.2

48.81

97.04

u/l

3.43

Fenamates

242

1.87

5.21

1.1

1.2

74.09

100.31

u/l

1.89

220

Coxarthrosis

179

836

1.45

5.20

1.2

1.3

88.04

97.03

u/l

0.59

159

730

Lumbar disc prolapse

225

1289

1.39

5.20

1.1

1.2

93.30

91.54

u/l

0.08

189

1131

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

3.15

5.19

1.3

1.1

107.36

84.33

u/l

0.36

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

186

882

1.44

5.19

1.4

1.2

96.28

86.15

u/l

0.65

161

759

Pulmonary heart disease

108

676

1.60

5.19

1.3

1.2

99.19

92.29

u/l

0.31

571

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

161

750

1.48

5.18

1.2

101.61

87.01

u/l

0.83

140

646

Fissure and fistula of anal and rectal regions

516

1.69

5.16

1.1

1.2

81.01

83.31

u/l

0.09

444

Fracture of skull and facial bones

412

1.78

5.16

1.2

116.83

84.31

u/l

1.16

361

Fracture of forearm

208

1394

1.40

5.15

1.2

75.48

85.21

u/l

1.13

180

1213

Viral infections characterized by skin and mucous membrane lesions

147

988

1.49

5.12

1.2

85.51

89.83

u/l

0.25

137

847

Aortic aneurysm

406

1.77

5.10

1.2

1.3

111.89

97.85

u/l

0.57

344

Radiculopathy

370

1.82

5.10

1.1

1.2

71.90

86.48

u/l

1.21

312

Dental caries 3, only avohilmo

324

1255

1.32

5.06

1.2

97.85

90.76

u/l

0.45

275

1115

Hernia of abdominal wall

156

1065

1.47

5.05

1.3

1.2

102.68

90.69

u/l

0.63

142

910

Stroke, including SAH

232

1249

1.38

5.04

1.3

1.2

109.96

89.44

u/l

1.13

200

1093

Ingrowing nail

2.78

5.04

1.4

1.1

97.50

78.36

u/l

0.42

Emergency coronary revascularization (for ACS)

185

929

1.43

5.04

1.2

1.3

113.55

96.25

u/l

1.05

160

797

Other pulmonary heart/vessel disease

2.92

5.04

1.3

1.2

158.12

76.25

u/l

1.64

Abscess of anal and rectal regions

128

2.43

5.04

1.2

1.1

75.16

87.04

u/l

0.23

106

Retinal detachment with retinal break

245

2.01

5.02

1.2

89.98

87.36

u/l

0.07

212

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

3.93

4.99

1.1

144.29

92.42

u/l

0.73

Specific personality disorders

479

1.70

4.88

1.1

1.2

99.32

82.65

u/l

0.58

418

Myalgia

502

1.68

4.87

1.3

1.2

76.84

90.73

u/l

1.07

434

Melanocytic naevi

106

672

1.58

4.86

1.3

1.2

86.95

86.20

u/l

0.03

585

Secondary right heart disease

3.01

4.83

1.3

1.2

158.00

76.29

u/l

1.39

Emotionally unstable personality disorder

188

2.14

4.83

1.1

1.2

85.18

86.66

u/l

0.06

163

Other renal tubulo-interstitial diseases

3.83

4.82

1.3

1.1

63.29

75.56

u/l

0.45

Coronary revascularization (ANGIO or CABG)

161

771

1.46

4.82

1.3

110.17

92.41

u/l

1.00

139

657

Atopic dermatitis

183

1104

1.42

4.82

1.3

1.2

87.53

88.53

u/l

0.04

163

975

Coronary artery bypass grafting

414

1.66

4.80

1.3

124.56

101.58

u/l

0.73

353

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

3.62

4.78

1.4

1.2

132.67

83.61

u/l

0.61

Multiple myeloma

3.62

4.78

1.4

1.2

132.67

83.61

u/l

0.61

Zoster [herpes zoster]

378

1.78

4.78

1.2

92.20

88.02

u/l

0.13

327

Haemolytic anaemias

3.19

4.77

1.2

140.28

80.35

u/l

1.16

Phlebitis and thrombophlebitis (not including DVT)

514

1.66

4.73

1.2

107.96

84.79

u/l

1.70

441

Other headache syndromes

156

1080

1.45

4.73

1.3

78.40

88.78

u/l

0.91

138

943

Fibroblastic disorders

530

1.65

4.71

1.3

100.44

94.23

u/l

0.21

457

Injuries to the shoulder and upper arm

297

1906

1.31

4.71

1.2

98.10

90.32

u/l

0.52

261

1666

Injuries to the elbow and forearm

252

1706

1.34

4.70

1.2

74.83

88.12

u/l

2.10

218

1488

Ischaemic Stroke, excluding all haemorrhages

201

1095

1.39

4.68

1.2

104.05

89.93

u/l

0.76

171

951

Excessive attrition of teeth

122

428

1.55

4.64

1.3

85.02

89.91

u/l

0.17

109

368

Hereditary hypogammaglobulinemia

14.69

4.63

1.1

1.2

120.86

56.20

u/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

203

1477

1.38

4.63

1.3

1.2

110.36

88.08

u/l

0.95

168

1290

Unstable angina pectoris

131

726

1.50

4.62

1.2

1.3

105.83

93.74

u/l

0.55

112

617

Special screening examination for infectious and parasitic diseases

293

1.76

4.59

1.2

77.53

81.80

u/l

0.17

251

COPD, hospital admission 2, with asthma infections

110

606

1.55

4.57

1.1

1.2

109.55

102.31

u/l

0.26

523

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

163

778

1.44

4.55

1.4

1.2

100.29

86.93

u/l

0.74

139

668

Trochanteric bursitis

319

1.83

4.52

1.1

1.2

86.31

80.45

u/l

0.28

282

Melanocytic naevi of lower limb, including hip

3.07

4.52

1.6

1.2

100.11

78.79

u/l

0.51

Pain in thoracic spine

327

1.81

4.49

1.2

76.04

82.86

u/l

0.26

281

Pneumonia derived septicemia

3.29

4.47

1.6

1.2

322.56

76.57

u/l

0.53

Melanocytic naevi of trunk

181

2.11

4.47

1.2

1.1

83.42

85.29

u/l

0.05

158

Other diseases of lip and oral mucosa

329

1.80

4.41

1.4

1.2

78.63

84.32

u/l

0.26

281

Malignant melanoma, excluding all cancers (controls excluding all cancers)

293

1.85

4.40

1.3

1.2

107.14

83.72

u/l

0.95

246

Other and unspecified mood [affective] disorders

2.63

4.39

1.1

88.52

90.83

u/l

0.05

Other follicular disorders

112

2.42

4.38

1.3

1.2

104.26

86.60

u/l

0.21

Sulfonylureas

131

707

1.48

4.37

1.3

131.49

89.74

u/l

2.48

119

604

Seborrhoeic dermatitis

163

2.16

4.36

1.5

1.1

73.96

85.66

u/l

0.60

140

Voice disturbances

102

659

1.55

4.36

1.3

1.2

89.49

84.42

u/l

0.23

569

Other disorders of the musculoskeletal system and connective tissue

316

1.81

4.35

1.2

80.65

85.04

u/l

0.19

275

Hyperaldosteronism

3.24

4.35

1.3

1.1

90.18

77.93

u/l

0.38

Unspecified lump in breast

421

1.69

4.30

1.3

1.2

68.43

77.18

u/l

0.58

373

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

2.97

4.29

1.2

1.1

302.67

86.60

u/l

0.52

Diffuse large B-cell lymphoma, helper endpoint

2.97

4.29

1.2

1.1

302.67

86.60

u/l

0.52

Gonarthrosis [arthrosis of knee](FG)

261

1163

1.32

4.28

1.1

1.2

89.82

95.60

u/l

0.37

222

1017

Mental and behavioural disorders due to sedatives or hypnotics

114

2.38

4.23

1.0

1.2

102.27

84.52

u/l

0.58

102

Localized swelling, mass and lump of skin and subcutaneous tissue

113

752

1.51

4.23

1.2

94.42

87.96

u/l

0.28

104

639

Cytomegalovirus infection, IBD co-morbidity

3.66

4.22

1.1

93.31

92.43

u/l

0.01

Other disorders of eye and adnexa

276

1.86

4.21

1.4

1.1

82.63

85.07

u/l

0.07

244

Abrasion of teeth

386

1.62

4.19

1.2

1.3

83.46

91.07

u/l

0.26

331

Sequelae of cerebrovascular disease

117

687

1.50

4.19

1.2

126.32

92.63

u/l

1.08

590

Superficial injury of hip and thigh

248

1.90

4.18

1.3

1.1

101.62

83.71

u/l

0.48

208

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

595

1.57

4.17

1.2

1.3

92.37

80.54

u/l

0.60

515

Symptoms and signs involving speech and voice

121

820

1.48

4.15

1.3

1.2

87.32

85.11

u/l

0.10

109

707

Alcohol use disorder, ICD-based

133

918

1.45

4.15

1.2

107.26

97.74

u/l

0.39

109

796

Other enthesopathy of foot (+metatarsalgia)

214

1.97

4.15

1.3

1.2

93.03

80.00

u/l

0.37

195

Multiple myeloma and malignant plasma cell neoplasms

2.61

4.14

1.4

1.2

129.50

89.50

u/l

0.70

Arthropathic psoriasis

235

1.92

4.14

1.2

1.1

76.95

90.48

u/l

0.53

203

Disturbances of skin sensation

612

1.56

4.13

1.3

1.2

75.51

88.55

u/l

1.24

535

Metatarsalgia

194

2.02

4.12

1.3

1.2

88.53

77.58

u/l

0.27

178

Other enthesopathies

109

725

1.51

4.10

1.3

1.2

92.09

90.93

u/l

0.04

628

Otitis externa

465

1.64

4.10

1.4

1.2

96.28

86.49

u/l

0.38

404

Follicular cysts of skin and subcutaneous tissue

382

1.71

4.08

1.3

1.2

86.46

89.30

u/l

0.10

330

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

310

1.73

4.07

1.2

101.56

87.65

u/l

0.44

268

Other disorders of iris and ciliary body

3.55

4.06

1.3

1.2

98.38

76.74

u/l

0.90

Corneal scars and opacities

3.37

4.05

1.2

1.1

104.00

73.58

u/l

0.75

Maternal care for other conditions predominantly related to pregnancy

415

1.67

4.04

1.2

79.09

80.46

u/l

0.08

367

Vocal cord dysfunction

168

2.05

4.04

1.2

72.56

70.98

u/l

0.06

146

Insomnia

324

1.77

4.03

1.2

79.39

89.65

u/l

0.41

281

Single spontaneous delivery

700

0.64

3.98

1.2

84.88

86.63

u/l

0.06

624

Palmar fascial fibromatosis [Dupuytren]

296

1.80

3.98

1.3

105.31

100.86

u/l

0.10

249

Faecal incontinence

197

1.99

3.97

1.4

1.2

86.06

78.85

u/l

0.21

168

Restless leg syndrome

246

1.88

3.96

1.1

1.2

58.23

87.23

u/l

3.59

217

COPD

153

898

1.41

3.95

1.2

107.58

91.52

u/l

0.91

130

775

Dental operations, only avohilmo

258

1009

1.31

3.93

1.2

108.65

97.94

u/l

0.53

224

885

Ventral hernia

549

1.57

3.92

1.3

1.2

94.45

87.76

u/l

0.22

468

Appendectomy

222

1624

1.32

3.88

1.3

1.2

104.73

88.06

u/l

1.40

204

1413

Fracture of foot, except ankle

496

1.60

3.86

1.5

1.2

100.42

83.91

u/l

0.59

434

Malignant neoplasm of digestive organs

127

869

1.44

3.84

1.2

1.3

175.11

92.26

u/l

1.66

110

747

Iridocyclitis

513

1.58

3.83

1.2

112.35

87.18

u/l

1.33

443

Traumatic subdural haemorrhage

210

1.93

3.81

1.1

1.2

117.81

95.59

u/l

0.54

181

Early onset COPD

522

1.58

3.79

1.1

1.3

115.10

91.62

u/l

0.87

448

Somatoform disorder

353

1.71

3.78

1.3

1.2

88.25

80.48

u/l

0.29

310

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

562

1.55

3.77

1.2

106.71

78.69

u/l

1.16

495

Later onset COPD, excluding more controls

279

1.71

3.73

1.2

103.53

83.17

u/l

0.73

232

Benign neoplasm of eye and adnexa

168

2.03

3.69

1.1

1.2

84.14

84.12

u/l

0.00

145

Hallux rigidus

304

1.75

3.67

1.2

74.33

83.81

u/l

0.45

262

Enthesopathies of lower limb, excluding foot

519

1.57

3.66

1.3

1.2

81.94

90.34

u/l

0.37

447

Sleep apnoea

330

1793

1.25

3.64

1.2

78.88

93.42

u/l

2.46

292

1568

Cytomegaloviral disease

3.29

3.63

1.1

1.2

93.31

93.97

u/l

0.01

Other diseases of gallbladder

2.55

3.63

1.2

112.55

70.31

u/l

1.11

Delivery

700

0.66

3.63

1.2

83.34

86.63

u/l

0.11

624

Pneumonia due to Streptococcus pneumoniae

2.87

3.63

1.6

1.2

116.19

81.60

u/l

0.41

Other surgical follow-up care

3.27

3.63

1.3

1.2

85.54

70.49

u/l

0.31

Conjunctivitis (acute, non atopic)

614

1.51

3.62

1.2

80.34

85.08

u/l

0.20

532

Infections with a predominantly sexual mode of transmission

641

1.50

3.58

1.2

102.93

82.23

u/l

0.88

564

Anterior Iridocyclitis

459

1.60

3.58

1.2

112.76

88.55

u/l

1.28

397

Congenital malformations of genital organs

156

2.05

3.55

1.1

1.2

120.59

76.92

u/l

0.42

138

Benign neoplasm: Small intestine

2.72

3.49

1.2

1.1

74.47

88.22

u/l

0.42

Acute and subacute iridocyclitis

431

1.61

3.49

1.2

112.31

87.13

u/l

1.33

370

Poisoning by drugs, medicaments and biological substances

510

1.55

3.47

1.2

104.88

84.41

u/l

1.16

445

Complications of the puerperium, not elsewhere classified

2.90

3.46

1.5

1.1

74.33

82.53

u/l

0.18

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.62

3.46

1.3

1.1

88.78

170.47

u/l

0.59

Other chronic obstructive pulmonary disease

144

867

1.38

3.43

1.2

109.75

92.65

u/l

0.92

122

749

Gonarthrosis

219

961

1.31

3.42

1.2

1.3

90.98

98.09

u/l

0.43

186

842

Idiopathic thrombocytopenic purpura

3.00

3.42

1.6

1.1

277.64

84.24

u/l

1.09

Other and unspecified follicular disorders

2.68

3.40

1.2

80.56

83.57

u/l

—

Angina pectoris

210

1084

1.31

3.40

1.2

100.57

88.56

u/l

0.85

189

939

Fall on and from stairs and steps

585

1.51

3.40

1.2

110.04

89.43

u/l

0.83

499

Poisoning by medicine

450

1.58

3.39

1.2

104.97

85.68

u/l

0.92

391

Sleep apnoea, including avohilmo

346

1823

1.23

3.39

1.2

76.70

94.48

u/l

3.77

303

1600

Carpal tunnel syndrome

222

1553

1.29

3.38

1.3

1.2

76.85

88.44

u/l

1.60

202

1356

Carcinoma in situ of skin of scalp and neck

3.74

3.36

1.1

159.20

105.23

u/l

—

Disorders of eyelid, lacrimal system and orbit

298

1875

1.25

3.35

1.3

1.2

89.59

91.87

u/l

0.12

257

1647

Abnormal findings in secretions and smears from cervix uteri vagina vulva

166

969

1.35

3.35

1.2

74.80

82.44

u/l

0.64

144

868

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

147

2.05

3.35

1.2

109.50

87.87

u/l

0.37

124

Benign neoplasm: Duodenum

3.47

3.34

1.3

1.1

75.55

94.22

u/l

0.34

Oral leukoplakia and related diseases, including avohilmo

175

1.95

3.33

1.4

1.1

81.24

79.44

u/l

0.05

154

Other skin changes

359

1.65

3.33

1.2

91.17

86.98

u/l

0.13

310

Psoriatic arthropathies, ICD10

226

1.82

3.27

1.2

1.1

67.81

86.78

u/l

1.54

196

Thyrotoxicosis with diffuse goitre

315

1.69

3.27

1.1

1.2

69.84

80.74

u/l

0.46

281

Oter anti-inflammatory and antirheumatic agents, non-steroids

299

1.54

3.24

1.2

85.70

102.48

u/l

0.81

269

Other epidermal thickening

2.52

3.21

1.4

1.2

128.50

76.83

u/l

0.84

Superficial injury of shoulder and upper arm

199

1.87

3.19

1.2

103.53

87.33

u/l

0.21

170

Delivery, wide proxy

560

0.64

3.15

1.3

1.2

80.30

84.44

u/l

0.20

498

Syphilis

2.98

3.14

1.3

1.2

150.00

75.95

u/l

0.91

Other disorders starting during childhood or adolescence

2.84

3.14

1.4

1.1

64.43

198.24

u/l

0.80

Barrett oesophagus

2.42

3.14

1.1

1.2

74.14

90.58

u/l

0.48

Alcohol-induced chronic pancreatitis

124

2.11

3.14

1.2

133.76

93.76

u/l

0.68

107

Coxibs

100

362

1.47

3.14

1.1

1.2

74.51

99.68

u/l

2.04

331

Ankylosing spondylitis, strict definition

2.64

3.13

1.1

83.25

87.81

u/l

0.09

Melanocytic naevi of lower limb, including hip

2.48

3.13

1.6

1.1

100.11

79.26

u/l

0.50

Bipolar affective disorders

373

1.61

3.13

1.2

106.50

79.73

u/l

1.15

324

Superficial injury of lower leg

532

1.51

3.11

1.3

1.2

78.44

87.57

u/l

0.60

466

Coronary angioplasty

118

645

1.41

3.11

1.2

1.3

110.36

94.16

u/l

0.73

102

547

Other disorders starting during childhood or adolecense, excluding more controls

2.82

3.08

1.4

1.2

64.43

176.35

u/l

0.68

Hemiplegia

2.34

3.08

1.3

1.2

118.40

79.73

u/l

0.94

Other diseases of upper respiratory tract

405

1755

1.20

3.07

1.3

1.2

80.65

97.28

u/l

2.91

355

1540

Dentofacial anomalies [including malocclusion]

562

1.48

3.02

1.3

1.2

150.99

85.72

u/l

0.69

485

Disorders of breast

181

1289

1.30

3.00

1.2

76.12

83.10

u/l

0.51

162

1140

Other crystal arthropathies

4.33

3.00

1.1

64.33

80.88

u/l

—

Ocular pain

140

2.01

3.00

1.3

1.2

69.26

73.85

u/l

0.14

124

Acute pharyngitis

231

1.77

3.00

1.5

1.2

111.69

85.56

u/l

0.31

194

Disorders of adrenal gland, other and/or unspecified

10.24

2.99

1.2

66.80

73.40

u/l

—

Rheumatic fever with heart involvement

10.23

2.99

1.2

65.60

74.40

u/l

—

Problems related to lifestyle

154

1.95

2.99

1.1

110.62

81.27

u/l

0.59

131

Other blood glucose lowering drugs, excl. Insulins

386

1.59

2.98

1.2

87.81

85.14

u/l

0.07

331

Mouth breathing

132

972

1.36

2.95

1.2

1.3

88.74

89.89

u/l

0.05

121

838

Unspecific neurodegenerative disorder

669

0.65

2.95

1.1

1.2

92.83

95.38

u/l

0.07

576

Other psoriatic arthropathies

213

1.79

2.91

1.2

69.03

88.26

u/l

1.42

183

Myocardial infarction, with ST-elevation

326

1.63

2.91

1.2

1.3

137.04

95.44

u/l

0.97

269

Ptosis of eyelid

228

1.76

2.90

1.2

112.88

80.90

u/l

0.99

203

Other specified disorders of kidney and ureter

2.61

2.88

1.1

305.47

76.58

u/l

0.44

Sequelae of injuries, of poisoning and of other consequences of external causes

534

1.48

2.87

1.2

87.80

86.49

u/l

0.04

466

Other obstructive and reflux uropathy

2.60

2.87

1.2

66.93

77.88

u/l

0.31

Fracture at wrist and hand level

106

757

1.40

2.87

1.1

1.2

88.48

89.67

u/l

0.03

661

Injuries to the wrist and hand

332

1988

1.21

2.85

1.2

91.63

91.19

u/l

0.02

290

1752

Dental caries 2

252

1592

1.24

2.85

1.3

1.2

91.15

86.02

u/l

0.27

225

1396

COPD related to multimorbidity

124

764

1.37

2.85

1.1

1.3

107.26

99.11

u/l

0.35

107

659

Colonic or urogenital fistula

659

1.43

2.84

1.1

1.2

81.83

90.34

u/l

0.45

563

Other diseases of the respiratory system

399

1.56

2.83

1.4

1.2

138.36

97.44

u/l

0.91

341

Other respiratory disorders and diseases

399

1.56

2.83

1.4

1.2

138.36

97.44

u/l

0.91

341

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

191

1214

1.29

2.83

1.2

82.65

84.55

u/l

0.11

169

1067

Complications of labour and delivery

150

1103

0.76

2.80

1.2

71.55

81.84

u/l

1.17

132

980

D07AA Corticosteroids, weak (group I)

283

1.66

2.80

1.1

1.2

94.37

84.31

u/l

0.40

246

Other neurological diseases

244

1576

1.25

2.80

1.2

96.17

91.73

u/l

0.24

214

1371

Other inflammation of eyelid

276

1.67

2.79

1.4

1.1

103.34

80.21

u/l

0.29

242

136

956

1.34

2.78

1.2

98.37

91.22

u/l

0.39

117

824

Crystal arthropathies, rheuma endpoint

3.95

2.78

1.1

1.0

64.33

68.67

u/l

—

Sensorineural hearing loss

179

1605

0.78

2.75

1.3

1.2

85.34

93.15

u/l

0.53

162

1396

Melanocytic naevi of trunk

217

1.76

2.75

1.2

1.1

83.42

86.81

u/l

0.09

189

Artrosis, including avohilmo

298

1337

1.22

2.74

1.2

85.35

98.02

u/l

1.36

261

1171

Dislocation, sprain and strain of joints and ligaments of thorax

2.61

2.71

1.3

1.2

73.07

74.15

u/l

0.04

COPD, hospital admissions

144

921

1.33

2.70

1.2

109.75

97.21

u/l

0.59

122

793

Rotator cuff syndrome

204

1198

1.27

2.67

1.2

92.36

95.01

u/l

0.13

177

1046

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.80

2.64

1.2

58.17

73.05

u/l

0.44

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

335

1.59

2.64

1.1

1.2

209.45

85.91

u/l

0.82

282

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

109

794

1.37

2.64

1.3

1.2

80.44

82.79

u/l

0.15

698

Superficial injury of wrist and hand

383

1.54

2.62

1.1

1.2

80.50

85.28

u/l

0.23

336

Generalized skin eruption due to drugs and medicaments

2.47

2.62

1.1

128.27

70.67

u/l

1.41

Diffuse large B-cell lymphoma

2.26

2.61

1.2

302.67

84.79

u/l

0.53

Other disorders of lacrimal gland

120

891

1.35

2.61

1.2

87.03

82.41

u/l

0.21

101

780

Alcohol dependence

554

1.45

2.61

1.1

1.3

107.91

99.91

u/l

0.22

475

Other endocrine disorders

2.26

2.58

1.4

1.1

270.11

97.16

u/l

0.39

Other diseases of oesophagus

163

1.85

2.57

1.5

1.1

60.88

80.80

u/l

1.19

138

Adverse effects, not elsewhere classified

410

1.52

2.55

1.3

1.2

70.58

87.40

u/l

1.27

363

Polyarthrosis

455

1.48

2.54

1.2

86.98

85.18

u/l

0.05

399

Other mental disorders due to brain damage and dysfunction and to physical disease

208

1.74

2.53

1.4

1.2

87.19

91.46

u/l

0.18

177

Abnormal spermatozoa

209

0.38

2.53

1.1

1.3

138.50

93.63

u/l

—

169

Pregnancy, childbirth and the puerperium

466

0.66

2.50

1.3

1.2

80.12

83.75

u/l

0.24

414

Dental caries 2 and operation codes

244

1580

1.23

2.49

1.3

1.2

91.88

85.91

u/l

0.31

217

1386

Malignant neoplasm of respiratory system and intrathoracic organs

386

1.51

2.48

1.1

1.2

101.49

94.82

u/l

0.14

329

Other chronic obstructive pulmonary disease, including avohilmo

173

1129

1.28

2.48

1.2

105.63

91.80

u/l

0.84

148

980

Hypothyroidism, strict autoimmune, 3 medication purchases required

291

1644

1.21

2.48

1.2

83.09

89.83

u/l

0.82

264

1428

Suicide or other Intentional self-harm

544

1.44

2.47

1.2

110.31

84.72

u/l

0.88

475

COPD, early/later onset

144

934

1.30

2.44

1.2

109.75

96.57

u/l

0.64

122

806

Basal cell carcinoma, including avohilmo

193

1211

1.26

2.43

1.2

99.98

90.29

u/l

0.57

166

1053

Benign neoplasm of eye and adnexa

196

1.74

2.42

1.1

1.2

84.14

85.78

u/l

0.03

173

Undefined dementia

176

0.36

2.41

1.0

1.2

105.14

106.99

u/l

—

149

Epilepsy

705

1.37

2.40

1.2

117.34

94.74

u/l

0.77

615

Chondropathies

328

1.56

2.39

1.2

1.1

86.48

84.37

u/l

0.06

284

Temporomandibular joint disorders

289

1.60

2.38

1.3

1.2

83.17

86.60

u/l

0.11

253

Late syphilis

3.68

2.37

1.5

1.2

123.75

73.12

u/l

—

Injury of eye and orbit

243

1.65

2.36

1.3

1.2

94.81

83.74

u/l

0.29

209

ILD-related respiratory insufficiency

2.63

2.36

1.0

1.2

110.50

104.05

u/l

0.09

severe traumatic brain injury, does not include concussion

434

1.48

2.35

1.2

110.28

96.03

u/l

0.42

367

Diseases of external ear

105

778

1.35

2.35

1.3

1.2

87.40

89.53

u/l

0.09

664

Diplopia

236

1.66

2.34

1.4

1.2

92.30

82.55

u/l

0.24

203

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

177

1.76

2.29

1.1

1.2

145.96

80.74

u/l

1.13

151

COPD-related respiratory insufficiency

230

1.66

2.29

1.1

1.3

119.50

95.84

u/l

0.43

199

Unspecified dementia

169

0.37

2.29

1.0

1.1

105.14

100.13

u/l

—

144

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

340

1.53

2.28

1.1

1.2

86.93

77.88

u/l

0.30

305

Pneumococcal septicemia

2.47

2.28

1.6

1.2

102.54

78.06

u/l

0.29

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

629

1.39

2.28

1.2

106.71

82.56

u/l

0.93

551

Autism spe, excluding more controls

3.50

2.27

1.6

1.1

72.50

87.61

u/l

—

Benign neoplasm: Other and unspecified parts of small intestine

3.92

2.26

1.0

1.1

68.29

81.31

u/l

—

Atrophic disorders of skin

334

1.53

2.23

1.2

113.96

79.36

u/l

0.52

293

General examination and investigation of persons without complaint and reported diagnosis

181

765

1.26

2.23

1.2

105.41

86.20

u/l

0.81

162

661

Other and unspecified rosacea

164

1.78

2.23

1.2

74.29

79.73

u/l

0.21

144

Graves disease, strict definition

202

1.69

2.20

1.1

72.21

76.97

u/l

0.12

180

Granulomatous disorders of skin and subcutaneous tissue

2.52

2.19

1.6

1.1

121.25

74.60

u/l

0.61

Atopic dermatitis, strict definition with reimbursement

590

1.38

2.18

1.2

88.48

84.84

u/l

0.11

520

Other noninfective disorders of lymphatic vessels and lymph nodes

2.25

2.18

1.5

1.1

70.73

75.74

u/l

0.09

Cervicalgia

469

1.43

2.13

1.2

67.59

86.10

u/l

1.91

395

Benign neoplasm: Small intestine

2.11

2.13

1.2

74.47

80.15

u/l

0.24

Basal cell carcinoma

185

1191

1.24

2.11

1.2

100.90

90.37

u/l

0.61

160

1033

Other neurotic disorders

2.06

2.11

1.6

1.2

75.62

81.01

u/l

0.22

Attention to artificial openings

2.46

2.10

1.7

1.2

132.92

101.86

u/l

0.35

Bacterial, viral and other infectious agents

145

1.80

2.10

1.2

84.40

89.29

u/l

0.12

127

Autism spe

3.22

2.10

1.6

1.2

72.50

70.00

u/l

—

Adhesive capsulitis of shoulder

405

1.46

2.08

1.1

1.2

81.30

86.53

u/l

0.21

345

581

1.36

2.07

1.3

1.2

102.83

89.81

u/l

0.57

509

Dermatitis due to substances taken internally

2.08

2.07

1.2

121.18

74.37

u/l

1.19

Occupational exposure to risk-factors

0.00

2.05

0.0

1.2

—

89.08

—

Olecranon bursitis

103

1.95

2.05

1.3

1.2

56.35

96.40

u/l

2.42

Skin changes due to chronic exposure to nonionizing radiation

124

911

1.29

2.03

1.2

99.23

91.99

u/l

0.36

106

783

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

326

1.51

2.02

1.2

90.46

86.43

u/l

0.16

286

Other symptoms and signs involving the circulatory and respiratory systems

2.01

2.00

1.3

1.1

72.39

91.65

u/l

0.66

Other benign neoplasms of skin

102

759

1.32

2.00

1.3

1.2

92.60

87.35

u/l

0.16

653

Other extrapyramidal and movement disorders in other diseases

509

1.40

2.00

1.3

1.2

69.07

85.28

u/l

1.08

439

Other disorders of the genitourinary system

311

1.52

2.00

1.3

1.2

67.98

83.83

u/l

1.11

275

Other and unspecified disorders of vitreous body

141

1111

1.26

1.99

1.3

1.2

69.86

87.06

u/l

2.74

125

965

Other hammer toe(s) (acquired)

391

1.44

1.99

1.1

1.2

88.06

85.19

u/l

0.13

339

Other disorders of nervous system

126

1.83

1.98

1.5

1.2

71.61

85.24

u/l

0.51

110

Melanoma in situ

2.29

1.98

1.2

1.1

117.85

85.72

u/l

0.51

Nummular dermatitis

141

1.78

1.96

1.7

1.1

112.63

84.90

u/l

0.41

119

Malignant neoplasm of skin

206

1278

1.21

1.96

1.3

1.2

101.75

88.87

u/l

0.93

180

1110

Meniscus derangement

172

951

1.24

1.95

1.2

1.3

80.05

98.45

u/l

2.35

146

830

Umbilical hernia

537

1.38

1.95

1.2

1.3

121.10

94.85

u/l

0.94

460

Seborrhoeic keratosis

495

1.40

1.94

1.4

1.2

85.20

81.41

u/l

0.10

420

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

548

1.37

1.94

1.1

1.2

158.67

82.85

u/l

0.66

480

Benign neoplasm: Duodenum

2.46

1.93

1.3

1.1

75.55

81.31

u/l

0.20

Benign neoplasm of urinary organs

2.16

1.88

1.4

1.1

100.79

84.21

u/l

0.52

Ganglion

490

1.39

1.88

1.2

74.48

90.40

u/l

1.27

430

Actinic keratosis

120

892

1.28

1.87

1.2

100.98

92.48

u/l

0.43

102

765

Pure hyperglyceridaemia

2.66

1.87

1.2

69.00

87.41

u/l

—

Autism

2.87

1.86

1.6

1.2

72.50

72.09

u/l

—

Haemorrhoids and perianal venous thrombosis

627

1.34

1.86

1.2

81.91

84.89

u/l

0.15

537

Ovarian cyst

135

616

1.27

1.85

1.3

1.2

83.73

86.20

u/l

0.14

120

539

Wide developmental disorders, excluding more controls

2.84

1.84

1.6

1.1

72.50

81.39

u/l

—

False labour

439

0.69

1.82

1.2

67.83

84.52

u/l

2.19

394

Toxic effect of ethanol

2.27

1.80

1.0

1.2

97.67

88.19

u/l

—

Benign neoplasm: Kidney

2.35

1.78

1.2

1.1

101.09

85.66

u/l

0.38

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

2.35

1.77

1.2

1.1

125.55

109.29

u/l

0.12

LSIL lesion of the cervix uteri, vagina or vulva

272

1.51

1.75

1.2

81.47

75.73

u/l

0.19

241

Chronic laryngitis and laryngotracheitis

321

1.47

1.75

1.2

76.29

86.42

u/l

0.60

274

Transient ischemic attack

169

1149

1.22

1.75

1.2

100.71

88.12

u/l

0.63

147

1002

Amputation of thigh

2.51

1.74

1.7

1.1

208.78

97.22

u/l

—

Dementia

716

0.75

1.73

1.2

107.87

94.11

u/l

0.35

616

Oxicams

323

1.36

1.72

1.1

1.2

79.64

104.98

u/l

1.77

292

Alzheimer disease

482

0.69

1.70

1.1

1.2

105.25

95.24

u/l

0.22

416

Conductive and sensorineural hearing loss

204

1678

0.84

1.67

1.3

1.2

84.40

94.20

u/l

0.77

186

1458

Acute epiglottitis

3.18

1.66

1.2

118.67

68.21

u/l

—

Unspecified event, undetermined intent

2.59

1.66

1.0

1.3

78.13

75.50

u/l

—

Dementia, including avohilmo

780

0.77

1.65

1.2

104.65

93.56

u/l

0.30

676

Superficial injury of ankle and foot

204

1.57

1.64

1.4

1.2

69.81

83.30

u/l

0.90

179

Spirochaetal infections, other/unspecified

165

1.64

1.2

1.1

91.18

84.36

u/l

0.12

146

Colorectal cancer, excluding all cancers (controls excluding all cancers)

520

1.34

1.63

1.2

172.94

90.63

u/l

0.76

448

Migraine with aura

513

1.35

1.61

1.3

1.2

77.42

81.41

u/l

0.22

455

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

106

1.80

1.58

1.1

1.2

100.36

102.90

u/l

0.05

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

3.02

1.58

1.3

1.1

91.33

80.67

u/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

320

1.36

1.58

1.3

1.2

65.78

83.06

u/l

1.22

284

Maternal care related to the fetus and amniotic cavity and possible delivery problems

100

748

0.79

1.57

1.3

1.2

75.30

82.92

u/l

0.40

674

Maternal care for known or suspected malpresentation of fetus

243

0.58

1.56

1.4

1.2

68.47

81.11

u/l

0.40

218

Suggestive for eosinophilic asthma

176

1.60

1.54

1.1

94.14

81.61

u/l

0.29

150

TMD related pain

2.17

1.50

1.4

1.2

94.64

76.91

u/l

0.32

Respiratory insufficiency

108

1.76

1.49

1.3

1.2

175.26

84.41

u/l

0.69

Acute suppurative otitis media

413

1.36

1.49

1.4

1.2

77.56

82.60

u/l

0.18

360

Other and unspecified injuries of ankle and foot

2.08

1.49

1.2

1.1

79.42

73.55

u/l

0.07

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

156

1270

1.20

1.49

1.2

72.88

94.75

u/l

3.72

141

1104

Plantar fascial fibromatosis

218

1.52

1.48

1.2

88.22

78.39

u/l

0.25

198

Otitis externa, unspecified

194

1.55

1.48

1.3

1.1

104.96

83.00

u/l

0.41

170

Familial hypercholesterolemia

284

1.45

1.47

1.1

1.2

98.86

91.73

u/l

0.20

239

Paracetamol of NSAID medication

165

1.44

1.45

1.2

1.3

68.71

104.37

u/l

1.66

148

Other malignant neoplasms of skin (=non-melanoma skin cancer)

173

1147

1.19

1.45

1.3

1.2

101.25

89.89

u/l

0.65

150

995

Hidradenitis suppurativa

2.12

1.44

1.5

1.2

126.00

77.98

u/l

0.37

Other disorders of breast

302

1.43

1.44

1.3

1.2

84.70

79.53

u/l

0.11

271

Disorders of lacrimal system

137

1130

1.21

1.44

1.2

86.04

85.02

u/l

0.05

115

979

Impetigo

2.04

1.43

1.6

1.1

112.25

88.94

u/l

0.28

Other and unspecified effects of external causes

594

1.30

1.43

1.3

1.2

71.65

85.38

u/l

1.27

521

Other and unspecified nonorganic psychotic disorders

378

1.38

1.43

1.1

1.2

75.49

86.70

u/l

0.56

332

Malignant neoplasm of small intestine

2.32

1.43

1.2

144.22

75.15

u/l

—

414

1.35

1.43

1.3

1.2

108.23

90.68

u/l

0.59

360

Malignant neoplasm of bronchus and lung

338

1.39

1.42

1.1

1.2

96.64

98.44

u/l

0.03

291

Other problems related to primary support group, including family circumstances

176

1.55

1.40

1.1

1.2

335.00

77.84

u/l

0.82

153

Acute gastritis

127

1.66

1.36

1.3

1.1

99.52

78.67

u/l

0.33

110

Early syphilis

2.96

1.36

1.0

1.2

192.00

81.33

u/l

—

Inflammatory diseases of female pelvic organs

204

1319

1.17

1.34

1.3

1.2

81.16

81.44

u/l

0.02

180

1172

Suppurative otitis media, unspecified

0.00

1.34

0.0

1.2

—

76.25

—

Emotional disorders and disorders of social functioning with onset specific to childhood

2.05

1.34

1.4

1.2

46.91

75.15

u/l

1.17

Acute nephritic syndrome

2.16

1.34

1.2

1.1

85.22

72.59

u/l

—

Emotional disorders starting during childhood or adolecense, excluding more controls

2.15

1.34

1.2

47.89

84.17

u/l

—

Correction of physiology of bite - very demanding therapy visit

2.15

1.34

1.2

111.33

75.73

u/l

—

Unspecified mental disorder

123

1013

1.22

1.33

1.1

1.3

79.64

86.65

u/l

0.55

110

882

Alzheimer disease, including avohilmo

562

0.76

1.32

1.1

1.2

96.73

94.86

u/l

0.05

488

Excessive, frequent and irregular menstruation

136

625

1.21

1.32

1.2

85.07

85.84

u/l

0.03

123

545

COPD, hospital admissions 1, only main diagnosis

671

1.25

1.31

1.2

1.3

102.77

100.06

u/l

0.09

574

Other and unspecified nail disorders

2.37

1.29

1.5

1.1

81.88

78.34

u/l

—

Malignant neoplasm of head and neck

153

1.57

1.28

1.3

1.2

101.59

88.69

u/l

0.24

131

Contact with sharp glass

2.09

1.27

1.1

1.2

61.80

80.85

u/l

—

Other and unspecified epidermal thickening

2.05

1.27

1.4

1.2

97.22

79.95

u/l

—

Rosacea

235

1.45

1.26

1.2

1.1

82.69

83.04

u/l

0.01

206

Cervical disc disorders

109

894

1.22

1.25

1.2

1.3

75.09

92.41

u/l

1.75

769

Deficiency of other B group vitamins

2.23

1.24

1.3

1.1

55.63

73.52

u/l

—

Psoriasis (vulgaris), strict definition

2.01

1.23

1.1

88.00

88.97

u/l

—

Calculus of lower urinary tract

1.77

1.23

1.1

55.00

87.84

u/l

2.29

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.91

1.23

1.3

1.1

123.67

70.72

u/l

1.08

Other abnormal products of conception

490

0.76

1.22

1.3

1.2

71.29

78.93

u/l

0.35

440

Wide developmental disorders

2.17

1.21

1.6

1.1

72.50

70.90

u/l

—

Other obstetric conditions, not elsewhere classified

336

1.30

1.21

1.3

1.2

65.74

83.72

u/l

1.32

300

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

628

1.26

1.21

1.3

1.2

91.00

86.29

u/l

0.18

555

Anorexia (incl.atypical)

1.80

1.21

1.4

1.2

67.71

86.31

u/l

0.44

Focal brain injury

101

1.69

1.19

1.1

1.3

107.08

87.70

u/l

0.23

Postmenopausal atrophic vaginitis

107

527

1.22

1.19

1.2

71.00

85.66

u/l

1.00

458

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

126

0.47

1.16

1.5

1.2

45.33

86.89

u/l

—

116

Other and unspecified hydrocephalus

0.00

1.16

0.0

1.2

—

69.69

—

Internal derangement of knee

792

1.22

1.15

1.2

1.3

90.98

95.09

u/l

0.18

687

LSIL lesion of the cervix uteri

191

1.47

1.13

1.1

1.2

82.17

74.97

u/l

0.24

168

Atopic dermatitis, strict definition

604

1.25

1.13

1.2

82.47

81.74

u/l

0.02

536

Alzheimer’s disease (Late onset)

365

0.70

1.12

1.1

1.2

109.33

100.61

u/l

0.14

314

Abnormal involuntary movements

267

1.39

1.12

1.3

1.2

87.62

83.40

u/l

0.09

229

Foreign body entering into or through eye or natural orifice

135

1.56

1.11

1.8

1.1

73.25

97.34

u/l

0.87

117

Melanoma in situ

1.79

1.11

1.2

117.85

82.97

u/l

0.61

Medial epicondylitis

1.79

1.11

1.1

1.2

95.25

83.73

u/l

—

Use of other anti-dementia drugs

430

0.73

1.11

1.1

1.2

102.17

98.72

u/l

0.06

369

Use of memantine

430

0.73

1.11

1.1

1.2

102.17

98.72

u/l

0.06

369

Benign neoplasm: Other and unspecified parts of small intestine

2.27

1.10

1.0

1.2

68.29

78.73

u/l

—

Fistulae involving female genital tract

2.27

1.10

1.1

1.2

49.86

54.36

u/l

—

Any dementia

619

0.80

1.10

1.2

115.65

92.60

u/l

0.60

540

Malignant neoplasm of colon

295

1.36

1.07

1.1

1.2

254.76

93.71

u/l

0.79

253

Wet age-related macular degeneration

332

1.33

1.07

1.3

1.2

100.17

89.64

u/l

0.36

284

Astigmatism

1.65

1.06

1.4

1.1

143.50

93.20

u/l

0.26

Open wound of wrist and hand

113

941

1.19

1.04

1.2

1.3

104.86

91.76

u/l

0.41

823

Foreign body in alimentary tract

1.67

1.04

1.3

1.1

105.80

103.72

u/l

—

Car occupant injured in other and unspecified transport accidents

376

1.30

1.02

1.2

83.24

89.43

u/l

0.21

331

Anti-inflammatory and antirheumatic products, non-steroids

383

1.22

1.02

1.1

1.2

106.89

96.49

u/l

0.25

351

Medical abortion

218

1044

1.14

1.02

1.2

89.19

80.33

u/l

0.60

192

921

Hallux valgus (acquired)

105

635

1.20

1.01

1.2

73.16

85.97

u/l

1.41

555

Other disorders of amniotic fluid and membranes

248

0.64

1.00

1.1

1.2

102.87

81.51

u/l

0.41

220

Other predominantly sexually transmitted diseases, not elsewhere classified

325

1.32

1.00

1.2

98.11

83.74

u/l

0.26

284

Benign neoplasm: Conjunctiva

1.84

0.98

1.2

1.1

77.67

94.77

u/l

—

Benign neoplasm: Kidney

1.81

0.98

1.2

1.1

101.09

76.78

u/l

1.18

Non-Hodgkin lymphoma, all

1.81

0.98

1.5

1.2

151.18

84.02

u/l

0.58

Presence of other functional implants

170

1049

1.15

0.98

1.3

1.2

107.56

85.94

u/l

1.40

155

904

Iridocyclitis in diseases classified elsewhere

2.18

0.98

1.2

1.1

106.60

68.41

u/l

—

Burn and corrosion of wrist and hand

1.86

0.96

1.1

62.60

72.67

u/l

—

Kela-code for severe mental illness

105

886

1.19

0.96

1.1

1.2

81.53

87.98

u/l

0.42

773

Other bullous disorders

1.77

0.94

1.1

103.56

73.23

u/l

—

Deviated nasal septum

759

1.20

0.94

1.4

1.2

79.89

95.58

u/l

0.91

660

Degenerative diseases of the nervous system

563

0.80

0.93

1.2

101.73

93.69

u/l

0.23

487

Use of rivastigmine

245

0.65

0.93

1.1

1.2

76.12

100.62

u/l

0.90

205

Other and unspecified nerve root and plexus disorders, also in other diseases

420

0.74

0.93

1.2

83.42

87.32

u/l

0.08

362

Cluster headache, strict

1.82

0.92

1.5

1.1

71.20

84.65

u/l

—

Other disorders of pigmentation

1.67

0.91

1.2

116.38

76.10

u/l

0.34

Alzheimer’s disease, wide definition

408

0.76

0.91

1.1

1.2

97.35

97.43

u/l

0.00

354

Obstructed labour due to malposition and malpresentation of fetus

480

0.76

0.91

1.2

71.15

87.91

u/l

0.77

429

Benign neoplasm of urinary organs

1.63

0.91

1.4

1.1

100.79

81.60

u/l

0.74

Focal epilepsy

438

1.26

0.89

1.1

1.2

122.20

87.20

u/l

0.90

376

Leiomyoma of uterus

222

1128

1.12

0.87

1.3

1.2

79.41

83.22

u/l

0.30

196

997

Major anomalies of jaw size

1.87

0.87

1.0

1.2

64.63

66.59

u/l

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

333

1.29

0.87

1.1

1.2

125.66

86.40

u/l

0.90

283

Migraine

138

1021

1.15

0.87

1.3

1.2

79.69

86.42

u/l

0.59

120

905

Contact with and exposure to communicable diseases

603

0.79

0.86

1.3

1.2

106.32

87.64

u/l

0.30

536

Toxic effects of substances chiefly nonmedicinal as to source

195

1.39

0.86

1.0

1.2

70.35

97.18

u/l

1.15

167

Coxarthrosis, primary

188

1451

1.13

0.85

1.2

84.58

91.54

u/l

0.52

166

1259

Gestational diabetes (for exclusion)

522

1.19

0.85

1.2

78.46

81.91

u/l

0.21

466

Postmenopausal bleeding

113

531

1.17

0.84

1.2

80.80

85.48

u/l

0.26

103

459

Female genital prolapse

564

0.84

0.82

1.1

1.2

66.27

85.66

u/l

2.36

488

Myocardial infarction, unclassifiable

405

1.23

0.79

1.2

123.54

102.35

u/l

0.48

340

Lesion of ulnar nerve

303

1.29

0.79

1.2

79.45

88.46

u/l

0.46

258

Acetic acid derivatives and related substances

358

1.19

0.78

1.1

1.2

102.49

100.63

u/l

0.04

327

Crowding of teeth, including avohilmo

1.49

0.77

1.3

1.2

79.41

86.57

u/l

0.09

Emotional disorders starting during childhood or adolescence

1.72

0.76

1.2

47.89

68.98

u/l

—

Other and unspecified tonsillitis

511

1.20

0.75

1.2

84.73

83.46

u/l

0.06

441

Desensitization to allergens

1.64

0.75

1.3

1.2

81.73

82.44

u/l

0.01

Other fall from one level to another

431

1.23

0.75

1.5

1.2

78.28

88.72

u/l

0.59

367

Persons encountering health services in other circumstances

798

1.17

0.74

1.4

1.2

116.20

82.76

u/l

1.91

684

Abnormal findings on diagnostic imaging of breast

2.01

0.73

1.0

1.2

79.00

76.80

u/l

—

Alcohol abuse, main dg, excluding more controls

263

1.29

0.72

1.1

1.2

115.21

88.31

u/l

0.50

224

All dysplastic lesions of the cervix uteri, vagina or vulva

613

1.18

0.71

1.2

85.08

81.68

u/l

0.12

547

Juvenile osteochondrosis

1.75

0.71

1.4

1.2

48.29

70.20

u/l

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

1.93

0.70

1.0

1.2

107.60

76.43

u/l

—

Polyp of the female genital tract

113

573

1.15

0.70

1.2

70.51

87.93

u/l

1.70

102

497

Glucosamine medication

134

1206

0.89

0.70

1.2

78.65

90.52

u/l

1.22

108

1051

Dissociative [conversion] disorders

1.71

0.70

1.1

76.86

84.20

u/l

—

Benign neoplasm: Conjunctiva

1.56

0.70

1.2

77.67

79.47

u/l

—

Cervicobrachial syndrome

527

1.20

0.69

1.1

1.2

78.74

89.17

u/l

0.56

454

Diseases of the ear and mastoid process

390

1836

1.08

0.69

1.3

1.2

82.90

92.57

u/l

1.18

346

1610

Benign neoplasm: Skin of eyelid, including canthus

292

1.27

0.69

1.2

66.97

83.56

u/l

1.74

246

Diseases of male genital organs

133

593

1.13

0.69

1.3

111.59

104.70

u/l

0.20

111

515

Colon adenocarcinoma

239

1.30

0.69

1.1

1.2

145.96

93.81

u/l

0.82

203

Disorders of eyelid in diseases classified elsewhere

1.64

0.68

1.0

1.2

59.30

75.13

u/l

—

Follicular lymphoma

1.64

0.68

1.1

1.2

82.10

83.18

u/l

—

Use of galantamine

120

0.58

0.67

1.1

1.2

102.00

101.39

u/l

—

101

Benign lipomatous neoplasm

757

0.84

0.66

1.1

1.2

69.67

86.98

u/l

1.33

646

Migraine without aura

411

1.22

0.66

1.1

1.2

81.67

79.70

u/l

0.08

371

Suppurative and unspecified otitis media

641

1.16

0.66

1.4

1.2

80.90

81.80

u/l

0.03

560

Glaucoma

174

1379

1.11

0.66

1.3

1.2

95.48

88.09

u/l

0.39

147

1201

Tonsillectomy and adenotomy

119

938

0.88

0.66

1.4

1.2

77.51

86.05

u/l

0.58

105

840

Lichen planus, including avohilmo

439

1.21

0.65

1.3

1.2

99.75

88.15

u/l

0.38

377

Diseases of inner ear

165

1457

1.11

0.65

1.2

82.84

88.53

u/l

0.31

146

1264

Cluster headache, wide

1.62

0.65

1.5

1.1

71.20

82.89

u/l

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

127

1121

1.12

0.64

1.3

1.2

97.04

87.77

u/l

0.28

114

969

Infective dermatitis

207

1.31

0.63

1.1

77.89

84.62

u/l

0.21

177

Effects of foreign body entering through natural orifice

488

1.19

0.62

1.3

83.64

90.51

u/l

0.23

416

Pollen allergy

330

1.23

0.61

1.3

1.2

82.86

83.54

u/l

0.02

292

Primary coxarthrosis, bilateral

716

0.85

0.60

1.2

78.65

90.72

u/l

0.70

610

Irregular menses

140

1021

1.11

0.59

1.2

77.12

81.19

u/l

0.29

128

903

Outcome of delivery

223

1.22

0.59

1.1

1.3

69.78

90.07

u/l

1.80

199

Benign paroxysmal vertigo

742

1.15

0.59

1.2

79.75

83.67

u/l

0.14

642

Non-small cell lung cancer, squamous, helper endpoint

1.53

0.59

1.2

1.1

125.55

118.56

u/l

0.05

Non-small cell lung cancer, squamous

1.53

0.59

1.2

1.1

125.55

118.56

u/l

0.05

Extrapyramidal and movement disorders

103

911

1.13

0.59

1.3

1.2

78.00

89.78

u/l

0.81

783

Benign neoplasm: Skin, unspecified

1.51

0.58

1.4

1.2

72.75

93.96

u/l

—

Acute appendicitis, no complications

155

1401

1.10

0.58

1.2

1.3

98.01

89.25

u/l

0.45

141

1213

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

649

0.85

0.58

1.1

1.3

88.20

90.03

u/l

0.06

562

Other spirochaetal diseases

650

1.15

0.58

1.1

1.2

78.00

83.25

u/l

0.24

560

Other specific arthropathies, wide

1.72

0.57

1.2

1.1

81.67

72.00

u/l

—

Nasal polyp

428

1.19

0.57

1.2

102.21

92.10

u/l

0.31

363

Oligomenorrhoea

1.48

0.57

1.3

1.2

93.75

73.19

u/l

—

Any dementia, excluding more controls

555

0.86

0.57

1.2

115.58

91.37

u/l

0.62

481

Vasomotor and allergic rhinitis

102

891

1.13

0.57

1.3

1.2

78.24

88.93

u/l

0.73

779

Other noninflammatory disorders of vulva and perineum

211

1.28

0.57

1.2

71.95

86.00

u/l

0.59

185

Other strabismus

455

1.18

0.56

1.4

1.2

120.16

85.10

u/l

0.59

399

Dental caries 2 and operation codes, only avohilmo

190

1287

0.92

0.56

1.3

79.94

93.21

u/l

1.27

168

1140

Tooth agenesis EXCLUDE clefts and syndromes

1.62

0.55

1.2

296.50

90.03

u/l

—

Disorders of vestibular function (Vertigo)

140

1258

1.11

0.55

1.2

87.25

86.65

u/l

0.02

123

1088

Chronic iridocyclitis

1.45

0.55

1.1

1.2

89.00

84.20

u/l

0.07

Glaucoma-related operations

107

1.40

0.55

1.1

1.2

157.00

84.43

u/l

—

Lyme disease

644

1.15

0.55

1.1

1.2

75.39

83.47

u/l

0.43

556

Diseases of middle ear and mastoid

147

1092

1.10

0.54

1.3

1.2

81.48

87.73

u/l

0.40

135

948

Long labour

469

0.84

0.54

1.4

1.2

80.10

83.59

u/l

0.14

419

Benign neoplasm: other/unspecified salivary gland

1.58

0.54

1.3

1.2

130.83

76.90

u/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

474

1.14

0.54

1.2

76.35

87.54

u/l

0.73

422

Achilles tendinitis

222

1.26

0.53

1.2

103.41

80.99

u/l

0.44

189

Unspecified abortion

125

1.36

0.53

1.2

1.1

96.47

71.20

u/l

0.50

112

Strabismus

580

1.15

0.52

1.4

1.2

126.47

86.02

u/l

0.89

506

Prolapse and hernia of ovary and fallopian tube

0.62

0.52

1.3

1.2

66.00

85.30

u/l

—

Gonarthrosis,primary

292

1717

1.07

0.52

1.2

89.35

93.55

u/l

0.29

251

1507

Other melanin hyperpigmentation

1.50

0.51

1.3

1.2

52.17

78.88

u/l

—

Cluster headache, strict, including avohilmo

1.47

0.50

1.5

1.1

71.73

75.96

u/l

0.11

Congenital malformations of the circulatory system

252

1.23

0.50

1.5

1.1

127.15

107.29

u/l

0.15

217

Chronic mastoiditis

1.47

0.50

1.0

1.2

112.67

74.58

u/l

—

Benign neoplasm: Larynx

1.47

0.50

1.0

1.1

83.67

92.25

u/l

—

Superficial injury of forearm

153

1.31

0.50

1.2

78.60

87.98

u/l

0.25

130

Cerebral aneurysm, nonruptured

180

1.28

0.49

1.2

1.1

80.56

77.17

u/l

0.12

161

Other specified/unspecified soft tissue disorders

1.41

0.47

1.2

94.58

76.68

u/l

0.33

Schizophrenia or delusion, excluding more controls

658

1.13

0.46

1.1

1.2

72.55

81.63

u/l

0.65

577

All dysplastic lesions of the cervix uteri

512

1.15

0.46

1.3

1.2

85.33

80.87

u/l

0.15

457

Assault by bodily force

120

1.33

0.46

1.4

1.2

107.06

102.23

u/l

0.06

105

Salpingitis and oophoritis

505

1.15

0.45

1.5

1.2

80.11

79.27

u/l

0.03

446

Chronic diseases of tonsils and adenoids

212

1440

0.93

0.45

1.3

1.2

70.18

90.19

u/l

4.44

187

1262

Pedal cyclist injured in transport accident

468

1.15

0.45

1.4

1.2

95.72

87.12

u/l

0.28

407

Anisometropia and aniseikonia

1.40

0.45

1.3

1.1

238.43

72.13

u/l

—

Other acquired deformities of musculoskeletal system and connective tissue

1.40

0.44

1.2

1.1

110.42

80.58

u/l

0.67

therapeutic use

1.38

0.44

1.6

1.1

147.14

74.52

u/l

—

Acute appendicitis

196

1722

1.07

0.44

1.2

1.3

103.10

90.73

u/l

0.83

181

1504

Gonarthrosis, primary, with knee surgery

175

1325

1.08

0.44

1.1

1.2

83.82

90.33

u/l

0.46

153

1157

Glaucoma suspect

107

972

1.10

0.43

1.2

91.74

85.00

u/l

0.27

836

Normotensive glaucoma

175

1.26

0.43

1.2

104.35

83.50

u/l

0.35

155

Primary gonarthrosis, bilateral

159

1286

1.08

0.43

1.2

87.77

88.31

u/l

0.02

137

1122

Other sexually transmitted chlamydial diseases

1.43

0.41

1.1

1.2

78.20

101.43

u/l

—

Diseases of appendix

213

1818

1.07

0.41

1.2

100.06

90.64

u/l

0.63

198

1588

Coxarthrosis, primary, with hip surgery

139

1215

1.08

0.41

1.2

83.56

90.29

u/l

0.50

124

1045

Benign leiomyoma with endometriosis

379

1.16

0.41

1.3

1.2

93.97

75.40

u/l

0.46

329

Malignant neoplasm of tongue

1.47

0.40

1.8

1.2

106.20

77.21

u/l

—

Combinations of oral blood glucose lowering drugs

653

1.12

0.40

1.2

1.3

106.97

84.05

u/l

0.83

558

Retinal breaks without detachment

352

1.17

0.40

1.3

1.2

91.35

87.14

u/l

0.12

309

Drug-induced adrenocortical insufficiency

1.43

0.39

1.2

103.80

76.50

u/l

—

Torsion of ovary, ovarian pedicle and fallopian tube

1.43

0.39

1.0

1.1

71.80

63.47

u/l

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

1.43

0.39

1.4

1.1

246.80

101.18

u/l

—

Other disorders of ear

264

1860

0.95

0.39

1.3

1.2

82.03

92.92

u/l

1.17

236

1625

Appendicitis, broad definition

211

1812

1.06

0.39

1.2

100.57

90.81

u/l

0.65

196

1583

Parkinson's disease, including avohilmo

313

0.83

0.38

1.4

1.2

96.30

91.04

u/l

0.13

269

Injuries to the neck

457

1.14

0.38

1.3

1.2

78.70

87.12

u/l

0.30

392

Inguinal hernia, bilateral

192

0.78

0.38

2.0

1.3

90.07

95.79

u/l

0.12

158

Organic, including symptomatic, mental disorders

137

915

1.08

0.37

1.2

97.27

93.27

u/l

0.15

123

785

Alzheimer disease, excluding more controls

245

0.84

0.37

1.2

85.17

95.90

u/l

0.18

215

Keratoconus

1.35

0.37

1.2

174.20

73.65

u/l

—

Type of accident

640

0.89

0.36

1.3

1.2

151.29

86.61

u/l

1.14

557

Female infertility

488

1.10

0.35

1.2

76.56

88.09

u/l

0.80

432

Other benign neoplasms of connective and other soft tissue

162

1.24

0.35

1.4

1.2

76.60

85.57

u/l

—

142

Alopecia areata

1.40

0.35

1.0

1.1

110.00

83.30

u/l

—

Manic episode

1.40

0.35

1.3

1.2

88.50

76.43

u/l

—

Pregnancy hypertension

114

950

1.08

0.34

1.2

69.64

83.62

u/l

1.76

107

843

Pedal cyclist injured in noncollision transport accidents

218

1.19

0.34

1.2

1.1

111.21

88.65

u/l

0.48

187

Endometriosis

111

609

1.08

0.33

1.2

85.27

86.87

u/l

0.06

533

Acute alcohol intoxication

519

1.12

0.33

1.1

1.3

102.98

99.30

u/l

0.06

448

Correction of physiology of bite - demanding therapy visit

118

1.27

0.33

1.4

1.1

63.13

79.09

u/l

0.66

101

Endometriosis of ovary

433

1.13

0.33

1.3

1.2

95.49

86.65

u/l

0.19

374

Persons encountering health services in circumstances related to reproduction

167

1064

1.06

0.31

1.3

1.2

82.26

94.63

u/l

0.78

148

946

Dental caries 3 and operation codes, only avohilmo

460

0.92

0.30

1.0

1.3

91.82

89.26

u/l

0.08

418

Cluster headache, wide,, including avohilmo

1.31

0.30

1.5

1.1

71.73

80.43

u/l

0.25

Other obstetric trauma

1.31

0.30

1.3

1.2

89.82

84.43

u/l

0.05

Inguinal or femoral hernia, bilateral

196

0.82

0.30

2.0

1.3

90.19

95.27

u/l

0.12

161

Dysplasia of cervi uteri

449

1.10

0.29

1.3

78.29

90.52

u/l

0.57

397

Colorectal cancer

515

1.11

0.29

1.1

1.2

195.90

94.52

u/l

0.72

440

Parkinson's disease

303

0.86

0.29

1.4

1.2

96.30

92.73

u/l

0.08

260

Alcohol abuse, main dg

297

1.15

0.29

1.1

1.2

115.21

92.87

u/l

0.39

249

Congenital malformations of heart and great arteries

224

1.17

0.29

1.5

1.1

132.23

106.38

u/l

0.16

195

Viral meningitis

1.23

0.29

1.3

1.2

66.86

85.58

u/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

535

1.10

0.28

1.3

1.2

98.13

85.66

u/l

0.48

464

Menorrhagia

115

593

1.07

0.28

1.2

88.38

87.76

u/l

0.02

107

516

Scleritis and episcleritis

112

1.25

0.28

1.4

1.1

86.43

73.99

u/l

0.24

Parkinson's disease, strict definition

280

0.86

0.28

1.5

1.2

93.21

93.45

u/l

0.00

240

Open bite

1.27

0.27

1.3

1.1

711.38

72.15

u/l

—

Polycystic ovarian syndrome, consortium definition

227

1306

1.05

0.27

1.2

79.32

82.11

u/l

0.21

211

1147

Alzheimer’s disease (Early onset), excluding more controls

1.24

0.27

1.1

1.2

58.75

94.04

u/l

—

Tinnitus

614

1.09

0.27

1.3

1.2

77.49

88.91

u/l

0.61

525

Presbycusis

289

1.14

0.26

1.1

1.2

81.50

102.51

u/l

0.99

243

Systemic atrophies primarily affecting the central nervous system

1.20

0.26

1.1

1.2

73.63

88.92

u/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

687

0.92

0.26

1.2

143.37

86.15

u/l

1.09

596

Serous carcinoma of ovary

0.67

0.26

1.6

1.2

91.80

70.74

u/l

—

Obstructed labour due to maternal pelvic abnormality

457

0.90

0.26

1.4

1.2

69.66

82.08

u/l

0.70

408

Hyperplasia of prostate

449

1.08

0.25

1.3

126.72

107.56

u/l

0.43

386

Nontraumatic intracranial haemmorrhage

415

1.11

0.25

1.3

1.2

130.63

85.47

u/l

0.66

358

Benign neoplasm of meninges

188

1.17

0.25

1.6

1.2

84.69

79.48

u/l

0.17

165

Alzheimer’s disease (Late onset), excluding more controls

192

0.87

0.24

1.2

105.35

97.53

u/l

0.10

165

Allergic rhinitis

679

1.08

0.24

1.3

1.2

79.15

85.75

u/l

0.32

600

Normal-pressure hydrocephalus

0.72

0.24

1.0

1.2

123.33

88.83

u/l

—

Allergic contact dermatitis due to drugs in contact with skin

1.32

0.23

1.2

1.1

112.20

79.48

u/l

—

Preparation and fitting of bite rail to mouth

296

0.88

0.23

1.3

1.2

64.46

82.64

u/l

0.75

257

Aneurysms, operations, SAH

369

0.89

0.22

1.2

86.48

82.80

u/l

0.17

319

Other degenerative diseases of the nervous system

470

1.08

0.22

1.2

91.63

91.79

u/l

0.00

411

Migraine without aura and triptan purchases

333

1.11

0.22

1.1

1.2

79.50

79.66

u/l

0.00

299

Blepharochalasis

804

0.93

0.22

1.3

1.2

79.32

82.77

u/l

0.14

701

Impingement syndrome of shoulder

603

1.08

0.21

1.1

1.3

93.56

90.09

u/l

0.10

530

Secondary polycythaemia

1.19

0.21

1.0

1.2

63.20

72.86

u/l

—

Other noninflammatory disorders of uterus, except cervix

510

1.07

0.21

1.2

74.31

82.64

u/l

0.61

439

Diabetes mellitus in pregnancy

422

1.08

0.21

1.3

1.2

86.72

81.02

u/l

0.24

375

Hypertrophy of breast

440

1.09

0.21

1.1

1.2

70.21

78.88

u/l

0.58

394

Noninflammatory disorders of female genital tract

119

632

0.95

0.21

1.2

77.62

85.10

u/l

0.50

106

552

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

1.25

0.20

1.0

1.1

98.17

75.74

u/l

—

Burn and corrosion of trunk

1.23

0.20

1.2

59.00

74.19

u/l

—

Benign neoplasm: Other and unspecified parts of mouth

1.23

0.20

1.5

1.1

77.17

86.74

u/l

—

Muscle strain

1.23

0.20

1.5

1.2

47.50

83.89

u/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.20

0.19

1.7

1.2

88.67

65.07

u/l

—

Other female pelvic inflammatory diseases

417

0.91

0.19

1.3

1.2

76.91

76.70

u/l

0.01

366

Temporomandibular joint disorders, including avohilmo

1023

0.95

0.19

1.2

76.60

82.99

u/l

0.37

901

Complications predominantly related to the puerperium

634

0.93

0.19

1.3

1.2

72.46

80.24

u/l

0.47

567

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

129

1077

1.05

0.19

1.2

66.67

82.95

u/l

2.63

122

953

Other diseases of spinal cord

1.21

0.18

1.7

1.1

92.29

83.81

u/l

—

Additional codes for the location of defect, injury or illness

100

1.20

0.18

1.3

1.2

60.75

81.54

u/l

1.03

Antenatal screening

310

0.93

0.18

1.2

1.3

59.74

88.94

u/l

5.01

282

Injury of nerves at wrist and hand level

0.76

0.17

1.0

1.2

70.00

75.29

u/l

—

Maltreatment syndromes

0.75

0.17

1.4

1.1

59.40

84.03

u/l

—

Use of ropinirole

0.71

0.16

1.6

1.1

74.60

81.37

u/l

—

Colorectal adenocarcinoma

398

1.08

0.16

1.1

1.2

125.66

92.08

u/l

0.72

337

Polycystic ovarian syndrome, broad definition

141

0.85

0.16

1.2

96.83

77.05

u/l

0.55

122

Gestational [pregnancy-induced] hypertension

565

0.94

0.16

1.1

1.2

59.06

84.32

u/l

4.48

498

Benign neoplasm: Skin, unspecified

1.11

0.16

1.4

1.2

72.75

80.74

u/l

—

Benign neoplasm: Cerebral meninges

203

0.89

0.15

1.2

88.54

77.63

u/l

0.36

179

Hypertrophy of breast in women and men

497

1.07

0.15

1.2

70.34

80.32

u/l

0.77

444

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

140

1.14

0.15

1.2

88.25

77.96

u/l

0.17

122

Hydrocele

207

1.11

0.15

1.1

1.3

105.71

100.58

u/l

0.07

168

Other benign neoplasms of skin

102

977

1.04

0.14

1.3

1.2

92.60

86.89

u/l

0.18

839

Bicipital tendinitis

0.81

0.14

1.0

1.2

125.43

78.55

u/l

—

Alzheimer’s disease, wide definition, excluding more controls

208

0.91

0.14

1.2

83.39

94.35

u/l

0.18

180

Mandibular retrognathia

0.80

0.13

1.0

1.1

93.50

78.78

u/l

—

Primary open-angle glaucoma, strict

635

1.05

0.13

1.2

90.75

87.11

u/l

0.11

538

TMD related operations

377

0.93

0.13

1.3

1.2

78.77

85.95

u/l

0.24

328

Benign neoplasm: Skin of eyelid, including canthus

344

1.08

0.13

1.2

66.97

84.91

u/l

2.07

299

Episcleritis

1.17

0.13

1.5

1.1

79.18

72.54

u/l

0.11

Other condition

277

1.08

0.12

1.3

1.2

217.68

86.17

u/l

1.28

238

Ectopic pregnancy

468

0.94

0.12

1.1

1.2

68.63

75.75

u/l

0.30

412

Migraine, single triptan purchase ok & required. ICD-code if available is included

226

1492

1.03

0.12

1.2

70.91

88.64

u/l

3.45

198

1320

Triptan medication for migraine, single purchase ok

226

1492

1.03

0.12

1.2

70.91

88.64

u/l

3.45

198

1320

Impacted teeth

244

0.92

0.12

1.2

47.21

82.99

u/l

3.25

215

Nontoxic goitre/thyroid nodule

845

1.04

0.12

1.2

60.72

83.58

u/l

4.64

738

Benign lipomatous neoplasm

612

1.05

0.11

1.1

1.2

69.67

84.07

u/l

1.01

525

Dental caries 2, only avohilmo

208

1603

1.02

0.11

1.3

1.2

80.61

86.99

u/l

0.56

184

1407

Benign neoplasm: Cerebral meninges

163

1.10

0.10

1.2

88.54

77.22

u/l

0.36

142

Other and unspecified disorders of skin and subcutaneous tissue

115

0.87

0.10

1.0

1.2

67.90

77.69

u/l

—

Spontaneous abortion

124

869

0.97

0.10

1.2

71.30

78.94

u/l

0.70

115

770

Disorders of refraction and accommodation

581

1.05

0.10

1.3

1.2

88.50

83.38

u/l

0.08

510

Moderate visual impairment, binocular

1.14

0.10

1.2

40.80

68.84

u/l

—

Peritonsillar abscess

422

0.95

0.09

1.2

87.32

91.62

u/l

0.11

363

Oral lichen ruber planus

1.04

0.09

1.4

1.1

99.20

72.84

u/l

—

Adenocarcinoma of pancreas

1.04

0.09

1.4

1.3

246.80

78.95

u/l

—

Varicose veins

184

1420

0.98

0.09

1.3

1.2

91.43

87.79

u/l

0.21

158

1240

Benign neoplasm: other/unspecified salivary gland

1.11

0.09

1.3

1.2

130.83

73.06

u/l

—

Other disorders of prostate

1.11

0.09

1.3

1.1

87.83

95.80

u/l

—

Benign neoplasm: Larynx

1.07

0.08

1.0

1.2

83.67

80.34

u/l

—

Disorder of external ear, unspecified

1.05

0.08

1.3

1.1

95.50

74.49

u/l

—

Postpartum haemorrhage due to anatomy

113

0.88

0.08

1.4

1.2

52.00

66.94

u/l

—

Acute lymphadenitis

1.14

0.08

1.5

1.1

100.50

88.20

u/l

—

Failed induction of labour

1.08

0.08

1.0

1.2

57.57

87.10

u/l

—

Benign leiomyoma with endometriosis

459

0.96

0.07

1.3

1.2

93.97

78.03

u/l

0.38

401

Pre-eclampsia or poor fetal growth

696

1.03

0.07

1.3

1.2

72.92

83.35

u/l

0.98

621

Alzheimer’s disease (Early onset)

1.04

0.07

1.1

1.2

58.75

90.95

u/l

—

Unknown and unspecified causes of morbidity

108

1.11

0.07

1.5

1.1

118.42

74.19

u/l

0.55

1.06

0.07

1.6

1.1

111.33

91.51

u/l

—

Later onset COPD

471

1.03

0.07

1.2

1.3

102.54

101.88

u/l

0.02

408

Follicular lymphoma, hilmo

1.12

0.07

1.1

1.2

82.10

85.81

u/l

—

Triptan medication for migraine, min. 3 purchases

143

1150

0.98

0.06

1.2

78.38

83.61

u/l

0.41

125

1021

Other hearing loss

668

1.03

0.06

1.1

1.2

82.39

100.54

u/l

0.98

569

Supervision of high-risk pregnancy

297

1.04

0.06

1.1

1.3

74.96

87.91

u/l

0.61

270

Other symptoms and signs involving the nervous and musculoskeletal systems

107

1049

1.02

0.05

1.3

1.2

107.34

85.63

u/l

0.57

909

Dislocation, sprain and strain of joints and ligaments of knee

147

1387

0.98

0.05

1.3

1.2

83.46

87.05

u/l

0.20

132

1209

Inguinal hernia

138

915

1.02

0.05

1.3

1.2

95.35

99.34

u/l

0.15

116

791

Glaucoma, exfoliation

222

0.95

0.05

1.1

1.2

114.31

86.00

u/l

0.33

187

Parkinson's disease, excluding more controls

242

1.05

0.04

1.4

1.3

96.30

96.40

u/l

0.00

210

Supervision of normal pregnancy

300

0.97

0.04

1.2

1.3

63.15

87.84

u/l

3.70

274

Artificial joint operation, meniscal resection

272

1825

0.99

0.04

1.2

85.79

93.85

u/l

0.81

237

1600

Other maternal disorders predominantly related to pregnancy

161

1024

0.99

0.03

1.2

80.23

80.44

u/l

0.01

149

908

Dental caries 1 and operation codes, only avohilmo

390

1.02

0.03

1.1

1.3

94.42

101.63

u/l

0.17

356

Parkinson's disease, strict definition, excluding more controls

226

1.04

0.03

1.5

1.3

93.21

96.49

u/l

0.07

197

Contraceptive management

109

774

0.99

0.02

1.4

1.2

71.38

91.41

u/l

2.24

686

Use of levodopa decarboxylase inhibitor

262

1.03

0.02

1.4

1.2

81.27

96.35

u/l

0.46

222

Schizophrenia, schizotypal and delusional disorders

741

1.01

0.01

1.1

1.2

75.11

87.72

u/l

0.90

650

Schizophrenia or delusion

741

1.01

0.01

1.1

1.2

72.55

87.76

u/l

1.27

651

Other disorders of eyelid

123

1197

0.99

0.01

1.2

86.74

88.24

u/l

0.06

108

1042

Propionic acid derivatives

383

1.01

0.01

1.1

1.2

112.46

96.49

u/l

0.36

351

Female infertility, associated with anovulation

1.06

0.01

1.2

1.3

74.80

78.32

u/l

—

Maternal care for known or suspected abnormality of pelvic organs

391

0.99

0.00

1.3

1.2

70.92

82.13

u/l

0.58

351

Primary open-angle glaucoma

795

0.99

0.00

1.2

95.06

89.21

u/l

0.18

686

Other menopausal disorders

521

1.01

0.00

1.2

76.99

86.09

u/l

0.48

450

Other benign neoplasms of connective and other soft tissue

198

1.01

0.00

1.4

1.2

76.60

82.06

u/l

—

174

Allergic contact dermatitis

295

0.98

0.00

1.0

1.2

112.79

80.72

u/l

1.05

263

Lateral epicondylitis

325

1.02

0.00

1.2

62.67

81.28

u/l

1.30

287

Pregnancy with abortive outcome

201

1054

1.00

0.00

1.2

81.43

80.13

u/l

0.07

175

931

Nontoxic multinodular goitre

505

1.01

0.00

1.2

59.88

82.73

u/l

2.91

439

Injury of muscle and tendon at shoulder and upper arm level

859

1.00

0.00

1.2

1.3

102.09

89.75

u/l

0.42

730

Chronic suppurative otitis media

121

0.99

0.00

1.5

1.1

69.67

85.80

u/l

0.41

107

Benign neoplasm of meninges

223

0.99

0.00

1.6

1.2

84.69

78.92

u/l

0.20

197

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.0

1.0

—

112.00

—

Congenital malformations of eye, ear, face and neck

0.93

0.00

1.1

206.33

82.28

u/l

—

Other infections specific to the perinatal period

0.00

0.0

1.2

—

25.40

—

Chondromalacia

0.91

0.00

1.0

1.1

72.00

80.25

u/l

—

Other facial nerve disorders

1.02

0.00

1.0

1.1

60.40

74.70

u/l

—

Slow fetal growth and fetal malnutrition

0.00

0.0

1.0

—

88.25

—

Other congenital malformations of heart

0.00

0.0

1.1

—

95.75

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.89

0.00

1.6

1.1

91.80

76.08

u/l

—

Placental disorders

0.00

0.0

1.1

—

65.88

—

Impacted maxillary canine

0.00

0.0

1.0

—

51.50

—

Subacute thyroiditis

0.98

0.00

1.3

1.1

72.33

74.71

u/l

—

Benign neoplasm: Other and unspecified parts of mouth

0.95

0.00

1.5

1.2

77.17

76.81

u/l

—

Endometriosis ASRM stages 3,4

580

1.00

0.00

1.3

1.2

93.16

78.58

u/l

0.44

511

Typhoid and paratyphoid fevers

0.00

0.0

1.5

—

85.67

—

Birth asphyxia

0.00

0.0

1.0

—

25.60

—

Congenital malformations of larynx

0.00

0.0

1.0

—

49.80

—

Vascular dementia (other)

0.00

-0.00

0.0

1.0

—

86.14

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS